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Toxoplasma gondii (T. gondii) is a parasitic protozoan that has been implicated in 
psychiatric disorders such as schizophrenia and bipolar disorder. While 33-50% of the 
world’s human population is infected with the parasite, not everyone with serum antibody 
levels to T. gondii exhibit psychiatric symptoms. In order to better understand under what 
conditions infection with T. gondii may lead to symptoms of schizophrenia, we studied 
the effect of four different infection factors on mouse behavior. Factors studied include: i) 
T. gondii stains used in infection, ii) sex of the infected host, iii) age at which the host is 
infected, and iv) T. gondii cyst persistence or immune response to infection. We found 
that each of these factors can contribute to the development of different behavioral 
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     CHAPTER 1: 
     Introduction  
 
Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan parasite found world-
wide. T. gondii can infect any warm-blooded mammal, humans included. Approximately 
33-50% of the world's human population is infected, as determined by serum antibody 
levels to the parasite. While already a large percent of the population is infected, it is 
postulated that due to climate change we may see an increase in the number of infected 
individuals (1).  
 
Infection with T. gondii has long been considered a major health concern for only 
immune-compromised and pregnant individuals. T. gondii can harbor in the brain of 
immune-competent individuals as semi-dormant parasite cysts. For those with 
compromised immune systems, the T. gondii cysts can rupture and stage convert into the 
actively replicating tachyzoite. The tachyzoites can then lead to Toxoplasma encephalitis 
(2). For pregnant individuals, T. gondii infection can adversely affect the fetus. For 
instance, T. gondii infection during the first trimester can lead to mental retardation, 
seizures, blindness, and death later in the child's life (3). 
 
It is now realized that T. gondii may also affect individuals with healthy immune systems. 
The parasite has been associated with various alterations in human behavior, and has 
been implicated in psychiatric disease, such as schizophrenia and bipolar disorder (4, 5). 
Evidence associating T. gondii infection with psychiatric disorders includes in vitro, in 
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vivo, clinical, and epidemiological studies. The greatest indication lies in studies looking 
at antibody levels to T. gondii in patients with schizophrenia and healthy age matched 
controls. Combining results from independent studies around the world revealed an 
increased risk [odds ratio (OR) = 2.73] of having schizophrenia if antibodies to T. gondii 
are present in serum (6). In addition, it has been observed that some people with acute 
toxoplasmosis also exhibit delusions and hallucinations reminiscent of schizophrenia (4). 
It has also been shown that anti-psychotics and mood stabilizers used to treat patients 
with psychiatric disorders have anti-Toxoplasma activity in vitro and in vivo. For 
example, in vitro replication of the parasite has been shown to be inhibited by anti-
psychotic (haloperidol) and mood stabilizers (valproic acid) (7). Also, these 
antipsychotics and mood stabilizers acted similarly to anti-T. gondii drugs in reversing T. 
gondii-induced behavioral changes in rats(8). While these data suggest a role of T. gondii 
infection in psychiatric disorders, one cannot ignore the fact that not everyone infected 
with T. gondii develops a disorder. It is therefore plausible that only under certain 
circumstances will T. gondii infection lead to the development of symptoms of 
psychiatric disorders. 
 
The ability to tease apart cause and effect (e.g. T. gondii infection and psychiatric 
symptoms) in humans is virtually impossible. For this reason, rodent models are 
important and useful tools as they can be manipulated in a controlled setting. In addition, 
when dealing with T. gondii infection, rodents are a suitable model because the parasite 
will undergo the same stage conversions as in humans. Mouse models of schizophrenia 
and rodent models of cognitive deficits due to T. gondii infection are discussed in 
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chapters 2 and 3. Using mice as a model, we sought to study the contribution of different 
factors to behavioral alterations in rodents.  
 
The first factor we looked at was the T.gondii strain (Chapter 4). There are many 
different strains of T. gondii in the world that are grouped into clades based on genetic 
similarity. Parasites between clades differ genetically by less than 1 percent. However, 
they are different in virulence and, relatedly, cytokine induction of the host (9, 10). 
Although strains from all clonal lineages have been isolated from humans, the majority of 
human toxoplasmosis cases have been associated with strains from the Type II clade (11). 
It is conceivable that although all T. gondii strains are capable of infecting humans, 
specific T. gondii strains may lead to the development of particular clinical presentations 
of psychiatric disorders in humans. 
 
The second factor we looked at was the sex of the host (Chapter 5). Studies looking at 
behavioral changes in men and women with serum antibodies specific to T. gondii have 
found a number of changes (5, 12-16). For instance, it was found that for both men and 
women, infection with T. gondii can increase the risk of being in a traffic accident (17).  
Surprisingly, infected men showed increased depression and were more withdrawn as 
compared to uninfected men, a finding not present in women. Also, while infected men 
showed less self-control and were less tidy, infected women had more self-control and 
were more tidy than their uninfected counterparts (18). Based on the clinical data, it is 
apparent that infection with T. gondii affects men and women differently.  
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The third factor we looked at was the age the host is first exposed to T. gondii (Chapter 
6). Onset of schizophrenia is during young adulthood, with onset for men in the late teens 
and for women in the early twenties.  At either of these ages, the brain is developmentally 
mature. In contrast, during adolescence the brain is immature and changing. Through this 
period, changes include maturation of interneurons and mesocortical dopaminergic 
projections and pruning of glutamatergic synapses (19). It is conceivable that infection 
when the brain is mature may have little impact, but pathogen insult during the 
adolescent period could have consequences on brain development that lead to the onset of 
psychiatric disorders during young adulthood.  
 
The fourth factor we looked at was the contribution of the immune response to T. gondii 
infection versus the persistence of parasite cysts in the brain (Chapter 7 and 8). T. gondii 
cysts  have been shown to express tyrosine hydroxylase homologs and contain dopamine 
(20). As an imbalance in dopamine is associated with psychiatric disorders, it is thought 
the parasite manipulates behavior through production of excess dopamine. However, T. 
gondii cysts have yet to be found in the brains of individuals with psychiatric disorders. 
To date, a serological response to specific T. gondii cyst antigens is used to identify those 
with (or whom might have had) parasite cysts (21). Recently it has been found that mice 
infected with an attenuated strain of T. gondii that renders them incapable of producing 
parasite cysts exhibit similarly altered behavior to mice that have parasite cysts(22). It is 
therefore plausible that while many humans are seropositive to T. gondii, perhaps only 
those unable to clear the parasite cysts from the brain are the ones who develop 
psychiatric disorders.  
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Using mice as a model host, we sought to study the contribution of 4 different factors to 
behavioral alterations in rodents. We believe that first understanding what condition(s) 
would lead to specific behavior changes will aid in elucidating how T. gondii infection 
alters behavior and in creating and testing pre-clinical compounds to be used in patients 




      
















     CHAPTER 2: 
 Mouse models of gene-environment interactions in schizophrenia 
   (published in Neurobiology of Disease, 2013) 
 
Abstract  
Gene-environment interactions (GEI) likely play significant roles in the pathogenesis of 
schizophrenia and underlie differences in pathological, behavioral, and clinical 
presentations of the disease. Findings from epidemiology and psychiatric genetics have 
assisted in the generation of animal models of GEI relevant to schizophrenia. These 
models may provide a foundation for elucidating the molecular, cellular, and circuitry 
mechanisms that mediate GEI in schizophrenia. Here we critically review current mouse 
models of GEI related to schizophrenia, describe directions for their improvement, and 
propose endophenotypes provide a more tangible basis for molecular studies of pathways 













Genetic and environmental factors, as well as their interplay, contribute to individual 
differences in vulnerability to psychiatric disease (23, 24). Gene-environment interplay is 
a term that encompasses several models (25, 26). These include altering gene expression 
by environmental factors via epigenetic mechanisms, additive interaction between genetic 
and environmental factors, gene-environment correlations or genetic control of exposure 
to the environment, and genetic control of sensitivity to the environment (25-27). Genetic 
moderation of individual susceptibility to the adverse or protective effects of the 
environment provides an explanation for most examples of what have been termed 
genotype-environment interactions (GEI) (26). This chapter will focus on mouse models 
that mimic GEI etiologically relevant to schizophrenia.  
 
GEI are difficult to assess in clinical studies (28, 29). Animal models offer a means of 
elucidating the contribution of genes, environmental factors, and their interactions on 
pathogenesis of psychiatric disease (30, 31). As technology has and continues to develop, 
a number of genetic models can be made to use in conjunction with environmental insults 
to look at GEI. However, the most useful models to study human disease should 
incorporate genetic changes and environmental components that are etiologically relevant 
(32, 33). 
 
As schizophrenia and related disorders are increasingly considered as disorders that 
include etiologies associated with brain development, rodent models with manipulation in 
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genes involved in neurodevelopment may be useful (19, 34). In a similar vein, it is 
important to take developmental considerations into account
 
when interpreting 
environmental effects that can be variable in different age groups.
 
For schizophrenia, pre- 
and postnatal events that induce psychological stress seem to exacerbate symptoms in 
adulthood, infectious etiologies have predominantly been associated with prenatal 
exposure, and illicit use of drugs has been found to be relevant during early
 
adolescence 
(27, 35).  
 
We have also proposed that promising animal models of GEI would include etiologically 
relevant genetic and environmental risk factors that would have strong functional impact 
and converge on common signaling pathways (33). Thus, we will overview mouse 
models that combine genetic variations with psychological stressors (36-38), immune 
activation (39, 40) and cannabis exposure (41-43). The present chapter will critically 
evaluate the weakness of the current approaches and will suggest possible new directions 
in the development of GEI models with a particular focus on endophenotypic measures 
that are thought to be instrumental for mechanistic studies, more readily translatable to 
human conditions, and targetable by therapeutics (44).  
 
2.2 Endophenotypes in animal models for GEI in schizophrenia 
As it is impossible to faithfully create the key features of schizophrenia such as 
hallucinations and delusions in animals, a more tractable and promising approach that has 
been gaining attention is to model brain circuitry, and cellular and molecular alterations 
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associated with the disease. Such alterations can be broadly termed as endophenotypes 
(45). In the context of GEI animal models, the main advantage of endophenotypes is that 
such abnormalities can be objectively measured in patients and faithfully replicated in 
animals to help decipher the underlying mechanisms of GEI. Here, we briefly overview 
several endophenotypes that are relevant to schizophrenia and may be utilized in basic 
studies of GEI.  
 
2.3 Behavioral endophenotypes 
Despite the obvious reservations about reproducing human emotion and cognition in 
animals, some behaviors are conserved in humans, primates, and rodents. Changes in 
some evolutionarily preserved behaviors are observed in patients and can be 
experimentally induced in animals, including hyperactivity, impaired pre-pulse inhibition 
(PPI) of the acoustic startle response, deficient social interaction, and cognitive deficits 
(23). Although these behavioral alterations are not specific to schizophrenia, their 
objectivity and reproducibility make them useful endophenotypes. For example, as PPI is 
diminished in patients with schizophrenia (46), testing for PPI impairment remains a 
critical component of any animal study of schizophrenia (47-49). Similarly, given that 
cognitive deficits are debilitating and the least treatable abnormalities in schizophrenia 
(50, 51), there is a growing appreciation for developing more sophisticated tests to 
evaluate cognitive processes, including working memory and attention (52, 53). 
Behavioral endophenotypes have been widely used in animal models of major psychiatric 
diseases and animal models of GEI. Still, more work is needed to develop translatable 
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and reproducible behavioral endophenotypes for negative symptoms and cognitive 
deficits of the disease (54).   
 
2.4 Electrophysiological endophenotypes 
Patients with schizophrenia display deficits in processing external stimuli from the 
environment (55-57). These deficits can be assessed with auditory event-related 
potentials (ERPs) methodology. Reductions in N100 or mismatch negativity and changes 
in theta and gamma frequency have been proposed as electrophysiological 
endophenotypes relevant to schizophrenia (58-60). Such endophenotypes can now be 
successfully measured in animals (45, 61, 62). Abnormal functional inter-regional 
connectivity has also been implicated in the pathophysiology of schizophrenia (63, 64). 
Newly developed tools enable us to study functional connectivity in laboratory animals. 
For example, reduced synchronization of neural activity between the hippocampus and 
the prefrontal cortex during a working memory task was found in a mouse model of the 
22q11.2 deletion (65). Another electrophysiological method that is being developed to 
examine the pathophysiology of cognitive impairment is stimulus specific response 
potentiation. This tool can be used to assess long-lasting, experience dependent plasticity 
in the primary visual cortex of rodents (66). These techniques are only beginning to be 
utilized in animal models of psychiatric disease but hold the significant promise of 
objectively evaluating effects of GEI at the circuitry level particularly in combination 





2.5 Brain imaging endophenotypes   
The introduction of neuroimaging has revolutionized brain research, providing significant 
insights into the pathophysiology of psychiatric diseases (67-70). Adaptation of 
neuroimaging to rodents has enabled researches to observe in vivo longitudinal changes at 
the organ, cell, and molecular levels (67, 71). Magnetic resonance imaging (MRI) has 
been used to assess volumetric changes in the lateral ventricles and brain regions in 
several animal models for schizophrenia (72-75). The animal variant of positron emission 
tomography (PET), micro-PET, has been helpful in assessing neurochemical changes 
(e.g. receptor binding) that resemble PET findings in patients (76). The simultaneous use 
of MRI and micro-PET in rodent models of schizophrenia may provide valuable 
information on changes in receptor density and neurotransmitter and metabolite 
concentration due to specific genetic or environmental manipulations (67). The 
significant advantages of in vivo neuroimaging are longitudinal monitoring of the brain 
alterations of GEI and the treatment effects in the same animal. However, the cost of 
neuroimaging is high and likely deters wider use of this technology. Also, low resolution 
of the images may make subtle changes difficult to assess, requiring the use of traditional 
histological methods.  
 
2.6 Histological endophenotypes (GABA neuronal changes and spines) 
Histological analysis provides insight into specific cell modifications (e.g. number or 
morphology) that still are unavailable with in vivo imaging. Decreased immunoreactivity 
of parvalbumin positive gamma-aminobutyric acid (GABA) interneurons in the cortex 
and hippocampus are commonly observed in postmortem brains of patients with 
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schizophrenia (77). This histological hallmark of the disease has been reported for many 
animal models of schizophrenia and is a promising endophenotype for GEI research. 
Similarly, abnormal maturation, morphology, and functions of dendritic spines and 
synapses have been associated with major psychiatric diseases (78). Although specific 
dendritic or synaptic abnormalities for schizophrenia have not been found, understanding 
the molecular underpinnings of synaptic pathology has been suggested to be a promising 
direction for future research on identifying new therapeutic targets (79, 80).  
 
2.7 Current animal models of GEI relevant to schizophrenia 
A number of animal models of schizophrenia have focused on manipulating genes in 
order to determine their contributions to disease. However, it is becoming increasingly 
apparent that genetic manipulations alone do not faithfully reproduce many 
endophenotypes of schizophrenia. Combining genetic risk factor with environmental 
adversities such as psychological stress, immune challenge, or drug exposure, provides a 
better approach to modeling the complexity and heterogeneity of schizophrenia. Here we 
review the GEI models grouped according to the type of the environmental factor used.  
 
2.7.1  Psychological stress  
Pre- and post-natal psychological stress has been implicated in the etiology of 
schizophrenia (38, 81). To better understand the role of stressful experience on the 
development of schizophrenia, a number of groups have exposed genetically modified 




One group sought to determine whether a combination of prenatal variable stress and a 
point mutation in the synaptosomal-associated protein of 25 kDa (SNAP25) would lead 
to behavioral endophenotypes reminiscent of schizophrenia. They found that prenatal 
stress and the genetic mutation acted synergistically to produce deficits in sociability and 
social novelty that were not seen in unchallenged mutants or stressed control animals. In 
addition, prenatal stress and the point mutation additively increased PPI impairment 
already present in mutant mice (82). This study was one of the first to demonstrate 
synergistic and additive effects of genetic and environmental factors on behavioral 
endophenotypes relevant to schizophrenia. However, the model has the limitations for 
molecular mechanistic studies of interactions between the point mutation in the Snap 25 
gene in the mouse embryo and an array of signaling pathways activated by stress in 
pregnant dams as the point mutation may or may not have functional effects on the 
intracellular stress response signaling. In addition, it is important to note that while this 
GEI model revealed impaired PPI, the point mutation in the Snap 25 gene has not been 
associated with schizophrenia. Rather, a reduction in SNAP25 expression has been found 
in the postmortem samples (83). 
 
The interaction of postnatal stress and deletion of a schizophrenia risk gene, Neuregulin-1 
(NRG1) has been looked at by a few groups. Desbonnet and associates (2012) examined 
the behavioral effects of interactions between repeated social defeat during adolescence 
(postnatal day 35-45) and deletion of NRG1. Independent of adolescent stress, mice 
deficient in NRG1 showed increased activity levels, deficits in PPI, and a reduction in 
social novelty preference. Interestingly, adolescent stress alone did not have an impact on 
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these behaviors. Rather, a combination of adolescent stress and NRG1 deletion was 
needed to observe decreased activity, poorer spatial working memory, and diminished 
sucrose preference (84). In NRG1 mice, stress also influenced spleen cytokine response 
to concanavalin A and altered expression of mRNAs encoding for brain cytokines and 
brain derived neurotrophic factor.   In contrast, acute restraint stress during adulthood (3-
4 months and 6-7 months of age) led to different effects. Older NRG1 mutants were less 
susceptible to the effects of stress on anxiety-related behaviors than younger mutants 
(85). These studies highlight that varying the time of exposure to stressful events leads to 
differential behavioral alterations in the same transgenic mouse model. A caveat of the 
NRG1 deficient model is lack of tissue specificity. NRG1 has an important role in cardiac 
development (86), with homozygous deletion or NRG1 leading to embryonic death from 
cardiac problems in mice (87). It is conceivable that NRG1 heterozygous mice have heart 
problems that affect brain functions. Future studies with this model should try to 
delineate the specific mechanisms of GEI (e.g. a role of NRG1 in the stress signaling 
pathways).  
 
Our group has recently provided a mechanistic insight into how a mild isolation stress 
during adolescence affects the mesocortical projection of dopaminergic neurons in which 
DNA hypermethylation of the tyrosine hydroxylase gene is elicited only if stress is 
combined with expression of a promising genetic risk factor, mutant Disrupted-In-
Schizophrenia-1 (DISC1) under the prion promoter. These molecular changes could 
contribute to several neurochemical and behavioral deficits that are blocked by a 
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glucocorticoid receptor antagonist. We propose that the biology and phenotypes of the 
mouse model resemble those of psychotic depression (88). 
 
2.7.2 Immune Challenge 
Viral infections have been implicated in the pathogenesis of schizophrenia (4, 89, 90). 
One possible mechanism whereby viral infections can contribute to schizophrenia is via 
secretion of pro-inflammatory factors by the host in response to infection (39). Notably, 
elevated levels of maternal serum cytokines have been associated with children who later 
develop schizophrenia (39, 91, 92). Mouse models of immune activation due to viral 
infection use the viral mimic polyinosinic:polycytidylic acid (poly I:C). Poly I:C is a 
synthetic analog of double-stranded RNA and, similar to a live virus, interacts with toll-
like receptor (TLR) 3 expressed by cells of the immune system (93).  
 
Prenatal immune activation with poly (I:C) has been used in a few models of GEI. One 
study combined prenatal administration of poly (I:C) during early gestation stage 
(embryonic day 9, E9) and expression of mutant human Disrupted in Schizophrenia 1 
(DISC1) and evaluated behavioral, brain imaging, spine density, and molecular markers 
that could be relevant to psychiatric disease. The initial hypothesis of the authors was that 
a combination of prenatal immune activation and mutant DISC1 would synergistically 
produce stronger phenotypes consistent with aspects of schizophrenia. However, 
prenatally exposed mutant DISC1 mice showed a set of neurobehavioral alterations that 
were not consistent with schizophrenia and were more similar to affective disorders, 
including increased anxiety and depression-like behaviors, decreased social interaction, 
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decreased volumes of amygdala and periaqueductal gray, and altered responses to acute 
retrain stress (94). Taking advantage of the inducible system in this transgenic mouse 
model, the authors also demonstrate that life-long expression of mutant DISC1 is 
required to produce the affective behaviors in mice. An unexpected outcome of the study 
was an emergence of previously unseen behavioral and brain abnormalities in mutant 
DISC1 mice. This result illustrates an important consideration for evaluating GEI models. 
Combining genetic and environmental factors can lead to the development of new 
phenotypes rather than exacerbation of pre-existing abnormalities. A potential caveat of 
the study is the predicted timing of expression of mutant DISC1 in selective neuronal 
population. Although the authors show expression of mutant DISC1 as early as E9 when 
poly (I:C) treatment is applied, additional studies are needed to better understand the 
regional and time-related expression pattern of this mutant protein during early gestation 
to inform future molecular studies with this model. A more detailed evaluation of timing 
of GEI in this model would be important as well, including the question if turning off 
expression in adult mice might improve some brain and behavior alterations.  
 
Meyer’s group also examined interactions between prenatal immune activation during 
late gestation stage (E17) and the heterozygous deletion of nuclear receptor related 1 
(Nurr1), gene that encodes for a transcription factor involved in dopaminergic neuronal 
development through activation of tyrosine hydroxylase (95). The combination of the 
genetic and environmental factors was found to not only exert additive effects on 
increased locomotor activity and deficits in sensorimotor gating, but also to produce 
synergistic effects on attentional shifting and sustained attention. In addition, Nurr1 
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deficiency in conjunction with prenatal poly (I:C) administration lead to improper 
development of prefrontal cortical and ventral striatal dopamine systems. This was 
suggested via reduced dopamine receptor 2 (D2R) in the nucleus accumbens and reduced 
tyrosine hydroxylase and increased catechol-O-methyltransferase (COMT) in the medial 
prefrontal cortex (95).  These molecular deficits are consistent with findings in patients 
with schizophrenia (96). However, a caveat of this model is the limited human relevance 
of the deletion as only missense mutations in the NURR1 gene have been associated with 
schizophrenia and manic-depressive disorder (97). Still, given a leading role of DA 
dysregulation in the pathophysiology of schizophrenia, one can foresee future research 
with this model of GEI in identifying the molecular mechanisms whereby NURR1 and 
the innate immune response from poly (I:C) administration work together to modulate 
maturation of DA neurons.  
 
Postnatal immune activation has also been studied in conjunction with DISC1. One study 
looked at neonatal (postnatal days 2-6) treatment with poly (I:C)  in transgenic mice 
constitutively expressing mutant DISC1 (98). Focusing on behavior and histological 
measures, they found that DISC1-poly (I:C) exposed mice showed reduction in working 
memory, increased susceptibility to MK-801 induced hyperactivity, and a decrease in 
parvalbumin positive GABA neurons in the medial prefrontal cortex. These deficits were 
not observed in mutant DISC1 mice without immune stimulation or control immune 
stimulated mice, suggesting synergistic effects. The authors focused on the 
characterization of schizophrenia-like behaviors in poly I:C/DISC1 mice and did not 
provide a detailed description of possible neurobehavioral effects following the single 
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factor exposure. In a follow-up study, cognitive impairment and MK-801 induced activity 
observed in poly I:C/DISC1 mice were improved by administration of clozapine (99). 
The ability of currently approved antipsychotic medication to ameliorate behavioral 
endophenotypes suggests that this GEI mouse model may be useful in the development of 
new therapeutics. A limitation of this model is that there is insufficient epidemiological 
support for childhood viral infection to increase the risk for schizophrenia. From a 
methodological standpoint, the model needs to control for possible maternal effects. For 
example, if poly (I: C) administration of pups resulted in sickness behavior, nursing dams 
may have treated sick and healthy pups differently, which may confound the outcomes of 
the study.  
 
Use of poly (I:C) administration in mouse models has distinct advantages in 
reproducibility, reliability, and simplicity. However, there are disadvantages. The route of 
administration (e.g. intraperitoneal or intravenous) does not mimic the route by which 
pregnant women are most likely to get infected by a virus (e.g. respiratory). The elicited 
immune response may differ from that produced by a live viral infection (100). To 
overcome the limited immune response due to poly (I:C), some have used live 
microorganisms to model human infections in animals (101, 102). A potential issue of 
this approach is our limited options for using live pathogens in rodents. Many relevant 
infections are species-specific and thus do not involve the same mechanisms of invasion, 
replication and dissemination (e.g., herpes simplex virus 1). In addition, C57BL/6 mice 
that are predominantly used in genetic models easily succumb to human pathogens (e.g., 
influenza virus or Toxoplasma gondii), complicating longitudinal behavioral studies. A 
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possible solution to this issue is to transfer the mutation in question to less susceptible 
Balb/C mice by a series of backcrosses or to treat animals with attenuated pathogens to 
better mimic the specificity and magnitude of immune activation. 
 
2.7.3 Drug abuse   
Cannabis use may precipitate schizophrenia in genetically susceptible individuals (43). In 
order to mimic this interaction, animal models utilize Δ-9-tetrahydrocannabinol (Δ
9
-
THC) that is the principal psychoactive component of the cannabis plant (103). A 
functional variant in the catechol-O-methyltransferase (COMT) gene (i.e., a switch in the 
amino acid methionine to valine in position 158) leads to greater COMT activity in the 
prefrontal cortex and resultant dysfunctions in humans (104). It has been found that 
adolescent cannabis exposure in individuals with the genetic variant in the COMT gene 
synergistically increased risk of psychosis (41).  
 
The interactions between COMT and cannabis exposure were evaluated in a series of 
elegant studies by John Waddington and colleagues. They found that COMT knock out 
(KO) mice chronically exposed to THC during adolescence exhibited behavioral and 
histological alterations reminiscent of schizophrenia (54, 105). COMT KO mice exposed 
to THC as adolescents showed decreased spatial working memory and anxiety, which 
were not seen in mice treated with THC in adulthood (54). Adolescent exposure to THC 
in COMT KO mice led to decreased size of dopaminergic neurons in the ventral 
tegmental area and parvalbumin positive GABA neurons in the prefrontal cortex, 
consistent with the similar endophenotypes in patients with schizophrenia (105). These 
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results further indicate the importance of timing of GEI and the utility of endophenotypic 
measures. As with many GEI models described, a caveat of this mouse preparation is a 
deletion of the COMT gene rather than a knock-in expression of the Val158Met 
polymorphism seen in humans (106).  
 
A number of studies were performed to assess the effects of acute and chronic THC 
treatments in adolescent and adult heterozygous Nrg1 KO mice, with a focus on behavior 
endophenotypes (107-111). A greater decrease in locomotion, elevated anxiety in the 
light-dark box test, and enhancement of PPI were more pronounced after acute THC 
treatment in adult NRG1 male mice compared to wild type littermates. A follow-up study 
did not find significant effects of acute THC in female mutant mice, indicating a major 
role of sex in modulating neurobehavioral outcomes of GEI in many mouse models. The 
same group of investigators also evaluated the behaviors in NRG1 mice chronically 
treated during adolescence with THC and found few effects (111). When adult mice were 
given chronic injections of a cannabis constituent cannabidiol (CBD) that has anxiolytic 
and antipsychotic properties (110), it did not alter the pre-existing behavioral 
abnormalities but selectively enhanced social interaction in NRG1 heterozygous (HET) 
mice. In addition to behavior, this group looked at receptor profiling versus 
autoradiography. They found that chronic THC exposure during adolescence increases 
binding in NRG1 KOs and decreases binding in wild-type of serotonin receptors in the 
cortex (110). The study also highlights a recurrent issue with GEI models, namely, that 
GEI do not always lead to exacerbation of pre-existing conditions but can be protective or 
produce new changes that were not originally present in mutants. A potential weakness of 
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this model is lack of human studies on association between cannabis and genetic variants 
in the NRG1 gene as well as our poor understanding of molecular interrelatedness 
between this gene and CB receptors signaling. Still, this type of interplay could provide 
interesting information on GEI relevant to schizophrenia (112).  
 
2.8 Future directions 
Recent progress in psychiatric genetics and epidemiology has facilitated the development 
of animal models of GEI relevant to schizophrenia. Although these models have provided 
some important insights, many caveats of recent preparations need to be addressed in the 
future studies. We would like to group the current issues into the methodological and 
technological ones. The former group calls for improvement of design and analysis of the 
existing models, while the latter one requires new technological approaches. 
 
2.8.1 Design weaknesses  
The field of animal models of GEI is still in its infancy but is rapidly expanding. As it 
continues to expand, it can learn from the studies of genetic models of psychiatric disease 
to avoid the known pitfalls. These include varying mouse background strains, history of 
breeding (e.g. inbred, outbred), and housing conditions. We believe that utilization of 
standard endophenotypic measures may not only help minimize variability in effects of 
GEI but also bring in new model organisms to study the molecular mechanisms of GEI 




Another issue is the under appreciation of sex-dependent effects. Many models 
demonstrate sex-dependent alterations, yet most GEI models focus on a single sex. Future 
research in GEI models should address if sex-specific abnormalities result from the 
effects of GEI or their individual components on actions of gonadal hormones or from the 
modulatory influence of sex hormones on the pathways involved in GEI. Advancing our 
knowledge of the underpinnings of sex differences in psychiatric disorders could help 
uncover risk/protective factors and develop better treatments. 
 
A promising direction in optimizing GEI model is to develop behavioral tests that are 
based on the natural murine behavioral repertoire (84). It has been proposed that more 
accurate behavioral evaluation of animal models of neuropsychiatric disorders should 
include species-specific behavioral approaches (113). Rodent specific tests will 
complement clinically relevant paradigms by providing more sensitive tests for analysis 
of underlying pathology (84) 
 
Further, schizophrenia is increasingly considered a disorder of brain development, animal 
models with manipulation in genes involved in neurodevelopment are going to be most 
informative (19, 34). It is important to take developmental considerations into account 
when interpreting environmental effects that vary across different time points (27, 35). In 
the past, addressing time-dependent interaction in GEI models has been achieved by 
changing the time when genetically modified animals are challenged with an 
environmental adversity. Future studies should also attempt to regulate timing of the 
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effects of a specific mutation as exemplified by a recent study with inducible expression 
of mutant DISC1 in mice prenatally exposed to maternal immune activation (94).  
 
Combining an environmental challenge with a genetic mutation can produce both 
protective and adverse effects. Instead of predicted synergistic effects, a GEI design can, 
for example, result in phenotypes previously unseen in unchallenged mutant mice (54, 
94, 105). Such results should be anticipated by designing future GEI experiments to 
avoid a trap of a limited set of pre-planned tests used to “capture” specific disease-related 
phenotypes. Appearance of new brain and behavioral phenotypes, particularly while 
using the genetic mutation implicated in various psychiatric conditions, could inform us 
about the role of environment in bringing about diverse clinical outcomes in patients with 
the same mutation. The Scottish pedigree with the disruption of DISC1 due to the 
chromosomal defect is a most prominent example of such a possibility (114). 
 
The focus of most published GEI research has been on risk factors. However, the 
contribution of protective factors is also important and has so far been relatively 
neglected, although there are some exceptions. Identification of genes conferring 
resilience to schizophrenia-related abnormalities is a new emerging research to uncover 
unrecognized molecular targets (115). New models using neurodevelopmental factors of 
resilience are clearly needed to advance this promising research. In this context, the role 
for environment enrichment in ameliorating/rescuing genetically produced abnormalities 
has been recently reviewed (116). Combining this type of preventive “therapy” with 
current GEI models would be interesting in determining whether environmental 
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enrichment can overcome effects caused by aversive environmental insults (e.g. 
psychosocial stress, infection, drug use) and offer a novel approach to treatments of the 
cognitive and negative symptoms that are resistant to the current antipsychotics (80, 117). 
 
2.8.2 Technology development   
The methodologies to manipulate the mouse genome at different levels of its organization 
(DNA, RNA regulatory sequences) are constantly improving. Simple knockout and 
transgenic technologies while remaining the workhorse of mouse genetics produce 
artificial systems inconsistent with the molecular pathology of schizophrenia. New 
models with mutations in regulatory elements in candidate genes with more subtle and 
temporally specific expression changes or human genetic variants knock-in models will 
better reflect the complex genetic and molecular mechanisms of schizophrenia (106). 
Therefore, time-dependent, circuitry- or cell-specific manipulations to target mRNA 
and/or proteins should be utilized.  
 
There is growing appreciation that combining multiple genetic mutations or several 
environmental factors in a single model could be more informative. Recent studies from 
John Waddington’s and Urs Meyer’s groups are an intriguing example of how one can 
proceed with more complex but etiologically relevant models of not only G x E but G x 
G and E x E interactions (118, 119). In addition to conventional breeding approaches, 
newer technologies include plasmid-based cell-type-specific and inducible expression 
systems using in utero gene transfer by targeting multiple genes (120). A complementary 
methodology is to suppress the expression of target genes using RNA interference 
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(RNAi) knockdown technology (121). Several susceptibility genes can be knocked down 
simultaneously in mice carrying multiple siRNA expression transgenes.  
 
Most studies have focused on neuronal functions of susceptibility genes. However, these 
genes are also expressed by glial cells (122, 123). Given, growing interest in the role for 
glia cells in mediating the effects of stress and microbial pathogens, GEI models with 
cell-specific perturbation of candidate genes are also needed. A recent study has provided 
the first evidence for the potential role of DISC1 in astrocytes, connecting DISC1 and 
serine racemase in modulating NMDA receptor functions (124).  
 
In conclusion, GEI animal models have already begun to provide new insights into the 
etiological complexity and heterogeneity of schizophrenia. We believe GEI animal 
models will continue to be a crucial tool to advance our knowledge about this debilitating 
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     CHAPTER 3: 
  Toxoplasma gondii and cognitive deficits in schizophrenia:   
    an animal model perspective 
   (published in Schizophrenia bulletin, 2012) 
 
Abstract  
Cognitive deficits are a core feature of schizophrenia. Epidemiological evidence indicates 
that microbial pathogens may contribute to cognitive impairment in patients with 
schizophrenia. Exposure to Toxoplasma gondii (T. gondii) has been associated with 
cognitive deficits in humans. However, the mechanisms whereby the parasite impacts 
cognition remain poorly understood. Animal models of T. gondii infection may aid in 
elucidating the underpinnings of cognitive dysfunction. Here, we (i) overview the 
literature on the association of T. gondii infection and cognitive impairment, (ii) critically 
analyze current rodent models of cognitive deficits resulting from T. gondii infection, and 












Cognitive impairment is an important feature and a serious problem in patients with 
schizophrenia. As many as 85% of patients exhibit some degree of cognitive dysfunction 
(50). While cognition encompasses many mental processes, seven domains are 
consistently impaired in schizophrenia: speed of processing, attention, working memory, 
verbal learning and memory, visual learning and memory, reasoning and problem 
solving, and social cognition. Three types of learning and memory that are severely 
affected are spatial, olfactory, and associative (125). Dysfunction can be present prior to 
the onset of psychosis, but more typically is observed concomitantly with positive 
symptoms. Unfortunately, treatment with anti-psychotics that can ameliorate positive 
symptoms do not significantly improve cognitive functioning (51). As the underlying 
mechanisms of cognitive impairment in patients with schizophrenia are not completely 
understood, the development of better therapies is impeded. 
 
Recently, there has been a growing interest in the role of infectious agents in the 
development of psychiatric disorders. Epidemiological and immunological clinical 
studies have identified microbial factors that may contribute to cognitive impairment in 
patients with schizophrenia. Herpes Simplex 1, Cytomegalovirus, influenza and the 
protozoan Toxoplasma gondii (T. gondii) have all been implicated in the development of 
memory deficits in both non-schizophrenic and schizophrenic individuals (126, 127). The 
role of T. gondii exposure in schizophrenia related cognitive dysfunction is interesting in 
that while all other candidate pathogens are viruses, T. gondii is thus far the only 
implicated protozoan. The parasitic infection may contribute to cognitive impairment by 
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affecting various brain systems, including glutamate (GLU) synaptic neurotransmission. 
Indeed, the role of GLU in schizophrenia and cognition has been extensively studied and 
is an important line of research. However, we still know very little about the exact 
mechanisms whereby T. gondii infection leads to cognitive impairment. Animal models 
of T. gondii infection can help advance our understanding of these mechanisms and 
facilitate identification of novel therapeutic targets.   
 
In this chapter we will (i) overview the literature on the association of T. gondii and 
cognitive impairment, (ii) critically analyze current rodent models of cognitive deficits 
resulting from T. gondii infection, and (iii) explore the possible mechanisms whereby the 
parasite may affect cognitive function. We will propose future directions in translational 
research with animal models of T. gondii infection.  
 
3.2 T. gondii infectious cycle 
T. gondii is an intracellular protozoan parasite that infects approximately a third of the 
human population (128). The three known clonal lineages of the parasite (Type I, II, and 
III) differ in their virulence, dissemination pattern, growth rate, immune response 
activation, and prevalence (10). Despite such differences, the three stages of T. gondii’s 
infectious cycle are common for all strains.  
 
In all species, the parasite starts its cycle of replication and dissemination with the 
tachyzoite stage. This parasite stage is present during acute infection, whereby 
tachyzoites actively invade any nucleated cell in the body, replicate asexually, and egress 
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to infect other cells, destroying the host cell in the process. The second stage is noted by 
the localization of bradyzoite tissue cysts in skeletal muscle and most notably, the brain. 
The dormant tissue cysts are present in all hosts and are characteristic of chronic 
infection. The third stage occurs only in the feline intestinal tract, and is characterized by 
the production of oocysts through sexual reproduction of the parasite. The infectious 
oocysts are excreted into the environment, where they can be transmitted to other 
organisms (2). Converging evidence indicates that T. gondii manipulates rodent behavior 
to facilitate the parasite’s transmission to the feline host. The behavioral effects of the 
parasite do not seem to be related to non-specific changes observed in sick animals but in 
fact suggest that the entire behavioral repertoire is affected to make an infected host a 
more likely prey for felines (128). 
 
Oocysts and cysts can be transmitted to humans in a number of ways, including 
consuming undercooked meat infected with cysts, drinking water contaminated with 
oocysts, or handling soil contaminated with oocysts. When oocysts or tissue cysts are 
consumed, the parasite converts into actively invading and quickly replicating 
tachyzoites. Under surveillance and inhibitory control by the host immune system, 
tachyzoites enter into the dormant tissue cyst stage. However, tissue cysts are capable of 
rupturing, with bradyzoites transforming back into tachyzoites (2).  
 
In humans, the transition of bradyzoites back to tachyzoites in the brain can have serious 
health consequences for immune compromised individuals (e.g. HIV-infected patients). 
The weakened host  immune system cannot control the parasite from continually 
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invading and destroying brain cells, which results in toxoplasmic encephalitis (2). As 
encephalitis is not observed in healthy people, it has long been thought that T. gondii 
infection only harms immune-compromised patients. However, it is becoming evident 
that T. gondii infection can also cause problems in immune competent individuals. 
Indeed, infection has been associated with a number of behavioral changes, including 
cognitive deficits.  
 
3.3 T. gondii and cognitive deficits in humans 
T. gondii exposure has been associated with cognitive impairment in non-schizophrenic 
and schizophrenic subjects. One of the first studies to evaluate the role of T. gondii 
infection in cognitive impairment was published in 1953 by Burkinshaw et al. They 
found that 89% of T. gondii seropositive patients at a mental institution had severe 
cognitive impairments, with an intelligence quotient (I.Q.) below the normal range (<70). 
However, they could not definitively attribute the mental defects to toxoplasmosis(128).  
Similarly, following a group of 24 children congenitally infected with T. gondii, Wilson 
et al. determined 4 (17%) of them had severe cognitive impairments (I.Q. range 36 – 62), 
while 6 (25%) showed a drop in intelligence over time (I.Q. score of 97 down to 74) 
(129).  
A few studies have associated T. gondii infection with less severe cognitive changes. In 
1973, Saxon et al revealed that children who were congenitally infected with T. gondii 
had significantly lower I.Q. scores (93.2) as compared with their age matched uninfected 
controls (109.8) (130).  Similarly, results from the Otis questionnaire conducted by Flegr 
et al revealed that young adult men (age 19-21) infected with T. gondii have lower verbal 
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intelligence as compared with their uninfected counterpart (129). Likewise, infected 
young adult men and the elderly (age 19-60) showed greater impairment in  delayed and 
immediate memory as compared with uninfected controls (129).  
 
One caveat of these studies is that the exact time of infection is unknown. As has been 
reviewed in detail by Jones et al, during pregnancy the risk of vertical transmission and 
severity of cognitive symptoms in offspring vary across the trimesters. For instance, 
while there is only a 10-25% risk of vertical transmission during the first trimester, 
exposure at this stage leads to mental retardation in offspring. In contrast, despite the fact 
that women who acquire T. gondii during the third trimester have a 60-90% risk of 
passing the parasite to the fetus, infection during this developmental stage produce 
minimal cognitive impairment in offpsring(3). While the study of Saxon et al. provides 
evidence for subtle cognitive changes due to congenital T. gondii infection, it is possible 
that infection during other life stages (e.g. puberty) may cause similar outcomes. Such 
information can be useful in the development of preventive medication. For instance, the 
prospective study performed by Saxon et al, included a group of congenitally infected 
children who were treated with sulfadiazine and pyrimethamine for the first month after 
birth. The I.Q. of this group at 2-4 years of age was comparable with age-matched 
controls, while that of the untreated group was significantly lower(130).  
 
Studies on the effects of T. gondii infection on cognitive dysfunction in people with 
schizophrenia are inconclusive. One study found no significant association between T. 
gondii infection and cognitive deficits in patients (aged 13-75 years old), although 
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seropositive subjects performed poorer on the Trail Making Test (TMT) than did 
seronegative patients. The age at which the individuals were first exposed to T. gondii 
was not mentioned (126). In contrast, Brown et al. reported that patients prenatally 
exposed to T. gondii exhibited worse executive functioning and memory than unexposed 
schizophrenics (131). This was evidenced by the increased number of errors made on the 
Wisconsin Card Sorting Test, and the greater length of time taken to complete part B of 
the TMT. As the study conducted by Brown et al. also included individuals prenatally 
exposed to influenza, it is difficult to unequivocally conclude that T. gondii infection 
contributed to cognitive dysfunction in individuals with schizophrenia. It is also unclear 
whether the cognitive deficits in infected patients are more severe than in seropositive 
controls. Although humans are not intermediate hosts for the parasite, memory or 
attention abnormalities in infected individuals might be a “side-effect” of parasite 
manipulation as discussed in detail elsewhere (128). As there is likely significant 
resemblance in the mechanisms whereby T. gondii impacts the brain and behavior of 
different species (128), rodent models will help to better understand how T. gondii 
infection contributes to cognitive deficits in infected patients.  
 
3.4 Cognitive abnormalities in T. gondii-infected rodents  
Cognitive effects of T. gondii have been evaluated in tests for spatial, olfactory, and 






Table 3.1       The Effect of T. gondii Infection on Learning and Memory in Rodents 
F= female; M= male 
Test Species Sex Finding Ref 
Spatial Learning and Memory 
Labyrinth 
Mouse, Rat F Impaired Learning (132) 
Mouse, Rat F Impaired Learning (133) 
Mouse F Impaired Memory (133) 
Rat F No Impaired Memory (133) 
Y-maze 
Mouse F Impaired Working Memory (134) 
Mouse F No Impaired Recognition Memory (134) 
Mouse F, M No Impairment (135) 
Mouse M No Impairment (136) 
Radial Arm Maze Mouse F Impaired Recognition Memory (137) 
Morris Water Maze Rat M No Impairment (138) 
Object Recognition Mouse M No Impairment (139) 
Olfactory Based Learning and Memory 
Social transmission 
of food preference 
Mouse F No Impairment (138) 
Mouse F No Impairment (140) 
Mouse M Impaired Learning and Memory (141) 
Associative learning and memory 




3.4.1 Spatial Learning and Memory 
Spatial learning and memory require the processing of external cues to complete a task. 
This is mainly studied in rodents through the use of mazes. The earliest reports on 
changes in spatial learning and memory due to T. gondii infection come from the studies 
in the late 1970s. Using labyrinth test, Piekarski et al found that chronically infected adult 
female mice and rats showed impaired learning as compared to uninfected controls (132). 
A year later, Witting’s study further demonstrated that T. gondii infection impaired 
learning in both acute and chronically infected adult female mice and rats. Learning 
impairment was observed as early as 2 days post infection (acute) and as late as 6 weeks 
post infection (chronic). Notably, memory was found to be affected differently between 
the two species, with only infected mice exhibiting severe memory impairment (133). 
 
Although the spatial learning and memory studies using labyrinth tests provided 
consistent and intriguing results, this task is no longer popular. Now, Y maze, radial arm 
maze or Morris water maze are commonly employed. Y maze is a useful tool for studying 
spatial working (short-term) and recognition (long-term) memory. Using Y maze, 
Kannan et al found that chronic infection of young adult Balb/C female mice (9 wks old) 
led to deficits in spatial working memory, but not spatial recognition memory. Curiously, 
while the effects of two Type II strains of T. gondii were compared, Pru and ME49, only 
infection with ME49 was associated with impairment of spatial working memory (134). 
Neither parasite strain produced deficiency in spatial recognition memory in the infected 
female mice, as determined by the similar amount of time control and infected groups 
spent exploring the novel arm (134). In a different study, mice were exposed to T. gondii 
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at one of three time points: (i) 8 weeks of age, (ii) congenitally by acutely infecting 
pregnant dams, or (iii) congenitally through mating of chronically infected females (135). 
It was found that male and female strain A albino mice, exposed at all three time points to 
the Beverley Type II strain of parasite, preferred the familiar arm over the novel one, 
while controls expectedly preferred the novel arm. Intriguingly, the groups exposed 
congenitally to the parasite spent more time in the familiar arm as compared with adult 
acquired infection group. The outcome was interpreted as T. gondii-induced neophobia 
(135). The increased neophobia in infected mice appears different from the behavioral 
responses seen in rats, although the rat studies used a different paradigm (143). Adult 
infected male mice demonstrated deficits in spatial recognition memory measured as lack 
of preference for either arm of Y maze (136).   
 
Radial 8-arm maze is also widely used to study spatial working and recognition memory. 
The increased number of arms compared to the Y maze adds complexity to the rodent’s 
task, helping to uncover more subtle deficits in learning and memory. One study with T. 
gondii infected rodents used radial arm maze to assess spatial recognition memory only. 
This task requires rodents to remember the maze arm with food rewards, in order to reach 
the food more quickly on following days. Compared to uninfected controls, chronically 
infected adult female mice (10 weeks of age) of a mixed Balb/C:C57BL/6 background 
spent more time searching for the food reward (137), suggesting a deficit in spatial 
recognition memory. Notably, this deficiency was not seen in chronically infected female 




Morris water maze (MWM) is another task to evaluate spatial learning and memory. As 
with Y and radial arm mazes, the MWM protocol can be modified to assess both spatial 
working and reference memory. Using MWM, Vyas et al evaluated the effects of T. 
gondii infection on spatial memory in rats (138). They found that control and chronically 
infected male rats spent the same amount of time in the quadrant that previously 
contained the escape platform, indicating no deficit in spatial memory (138). Spatial 
recognition memory in infected rodents was also examined in object recognition and 
spatial placement tests. It was determined that chronic infection of 8-week-old C57BL/6 
male mice did not affect cognitive functions in these tests (139).  
 
3.4.2 Olfaction based Learning and Memory 
The social transmission of food preference (STFP) test is based on olfaction and 
represents another type of cognitive test used in infected rodents. This task requires intact 
olfaction and sufficiently high levels of social non-aggressive interactions. Two groups 
used STFP to evaluate cognitive effects of chronic T. gondii infection in young adult 
Balb/C mice. Both studies found that T. gondii infection did not affect learning and 
memory in female mice as evidenced by their consuming greater amounts of “familiar” 
food (the one that was previously presented by a social partner) compared to “novel” one 
(138, 141). In contrast, memory deficit was observed in infected males, as evidenced by 
consumption of similar amounts of both types of food. Notably, gender-dependent effects 
of T. gondii on olfaction-related behaviors have also been documented in human studies. 
Flegr et al. found that cat odor attractiveness increased for infected men while decreased 
for infected women (15).  
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3.4.3 Associative Learning and Memory 
Associative learning and memory can be studied in active and passive avoidance tests. To 
date, only one study has evaluated the effect of congenital exposure to T. gondii on 
passive avoidance in adult mice. In this study, mice were exposed to T. gondii at 
embryonic day 5, 10, and 15. It was found that congenital infection during early and 
intermediate gestation (5 and 10 days respectively) but not late gestation (15 days) leads 
to impaired passive avoidance in adult mice. This was demonstrated by a shorter latency 
time to enter the dark chamber, as well as a greater number of entries into the dark 
chamber (142).   
 
The inconsistent results of the rodent studies can be explained by experimental 
differences, including rodent sex, species, and strain (144). For example, direct effects of 
T. gondii on sex hormone production and the role of sex hormones in susceptibility to 
infection were shown to influence sex-related cyst burden and temporal differences in 
cytokine production in the brain (145, 146). Such differences can contribute to sex-
dependent behaviors, emphasizing the importance of testing male and female animals. 
With regard to species-specific differences, milder cognitive abnormalities were reported 
in rats compared to mice. The variable outcomes could be explained by differential 
resistance between two species. Unlike mice, rats are less susceptible to T. gondii 
infection and exhibit the clinical course and in utero transmission that may better mimic 
the human situation (144). Notably, greater resistance in rats appears to be related to later 
stages of infection as the early dissemination of parasites has been found to be very 
similar between species (147). However, it remains unclear how species-specific brain 
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physiology and behavioral biology can contribute to variable cognitive deficits produced 
by T. gondii.  
 
3.5 T. gondii effects on the brain 
Numerous studies have evaluated the molecular, cellular and immune effects of T. gondii 
on the brain. In vitro experiments have demonstrated that tachyzoites infect and form 
cysts within microglia, astrocytes, and neurons (146). Activated microglia and astrocytes 
limit parasite replication and spread by stimulating expression of the NF-kB family of 
transcription factors to regulate production of pro- and anti-inflammatory cytokines 
(146). In turn, cytokines (e.g. IL-1, IL-6, and TNF-alpha) can influence synaptic 
neurotransmission and potentially contribute to cognitive deficits (148).  
 
In addition to the effects of immune activation (e.g. indirect mechanisms), it has been 
recently shown that the parasite itself is able to affect dopamine neurotransmission in the 
brain (e.g. a direct mechanism). McConkey and his colleagues in a series of elegant 
experiments have demonstrated that the parasite expresses homologs of enzymes 
involved in the dopamine synthesis pathway: phenylalanine and tyrosine hydroxylase 
(149). In vitro work with PC12 cells has demonstrated that T. gondii cysts can increase 
cellular release of dopamine (20). Additionally, in vivo work has shown that parasite 
cysts can synthesize dopamine, and that infection increases whole brain dopamine levels 
in infected mice (150). Yet, a recent  study reports no changes in monoamine content in 
the frontal cortex and striatum of congenitally infected CD-1 mice (151).  Future studies 
are clearly needed to further evaluate alterations in dopamine neurotransmission in 
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infected rodents in vivo and link these changes to behavioral abnormalities, including 
cognitive impairment. However, it seems less likely that only dopamine changes will be 
able to explain the entire spectrum of behavioral responses in infected animals. It seems 
that more attention should be paid to glutamate (GLU) neurotransmission, alterations in 
which have been strongly associated with cognitive dysfunction in schizophrenia.  
 
Administration of non-competitive N-Methyl-D-aspartic acid  receptor (NMDAR) 
antagonists, phencyclidine (PCP) and ketamine, to non-psychotic individuals can lead to 
behavioral changes that mimic positive, negative, and cognitive symptoms, including 
alterations in attention, memory, and reasoning. Subsequent studies using NMDAR 
antagonists, brain imaging, human postmortem samples, genetic approaches, and pre-
clinical animal models have provided further evidence of the importance of GLU and its 
receptors in cognitive functioning (152). These studies have suggested that dysfunction in 
NMDAR may be responsible for aspects of cognitive deficits in people with 
schizophrenia. However, it has been recently proposed that hyper function of NMDA 
receptors mediated through activation of alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors can also contribute to the pathophysiological 
mechanisms of cognitive impairment in schizophrenia (152). 
 
The link between T. gondii and changes in GLU neurotransmission remains poorly 
understood. Up-regulation of a glutamate receptor antagonist has been mostly evaluated. 
An  endogenous metabolite of tryptophan metabolism and a NMDA receptor antagonist, 
kynurenic acid (KYNA), has been hypothesized to be a pathogenic link between T. 
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gondii infection and cognitive impairment in schizophrenia (153). Elevated levels of 
KYNA can lead to excessive stimulation of the NMDAR, affecting GLU 
neurotransmission and resultant cognitive function (153). Thus, diminishing elevated 
KYNA levels is predicted to ameliorate cognitive deficits. Knockout mice with deletion 
of the enzyme that converts kynurenine into KYNA, kynurenine aminotransferase II, 
have lower levels of KYNA and perform better in cognitive tests compared to control 
mice (154). As rodents infected with T. gondii and patients with schizophrenia have 
increased brain levels of KYNA (153), one could predict that reduction of levels of this 
NMDA antagonist may have therapeutic effects. 
 
The GLU system can also be affected by the host immune system’s response to T. gondii 
infection via secreting cytokines (e.g., IL-6 or TNF-alpha)(148). Another immune 
mechanism of GLU synaptic dysfunctions may be related to production of anti-NMDA 
receptor antibodies. Indeed, recent studies have implicated autoantibodies to the NMDA 
receptor in the causation of cognitive deficits (155). While it remains to be seen whether 
such autoantibodies are produced by T. gondii infection, it has been reported that the 
infection-induced IgG antibodies are able to cross-react with neural epitopes, including 
the NMDAR (156). It is also possible that the immune response to the parasite could alter 
numbers of NMDAR similar to the decreased expression of NMDAR due to prenatal 
infection with cytomegalovirus (157). In addition, T. gondii could impact NMDAR 
functioning by affecting major histocompatibility complex (MHC) signaling (158). 
Indeed, T. gondii infection has been shown to decrease neural MHC II expression (159), 
which has been associated with cognitive deficits in CD4 KO mice (160). Collectively, 
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these studies suggest that the host immune response could affect GLU neurotransmission, 
resulting in cognitive impairment in infected individuals. However, more studies are 
clearly needed to provide a better understanding of the underlying molecular pathways. 
 
3.6 Future directions 
Rodent models of cognitive dysfunction associated with T. gondii infection disease are 
important for advancing our knowledge of the molecular pathogenesis and the 
development of therapeutics. However, there are still several lines of work that need to be 
improved. In addition to schizophrenia, cognitive impairments are associated with other 
disorders, including obsessive-compulsive, bipolar disorder and Alzheimer’s disease 
(161, 162). It is possible that there is substantial commonality in the pathophysiology of 
cognitive dysfunction in all these illnesses. Therefore, to create a more comprehensive 
rodent model of cognitive impairment associated with schizophrenia, it is necessary to 
model other schizophrenia-like behavioral changes as well (163).   
 
Given that microbes probably interact with genetic factors to contribute to psychiatric 
disease, there is a need in developing animal models based on interactions between T. 
gondii infection and candidate genes, e.g., Disrupted in Schizophrenia 1 (DISC1). DISC1 
was first identified in a balanced chromosomal translocation (1:11) (q42.1; q14.3) that 
segregates in a Scottish pedigree with major mental disorders (164). DISC1 is located 
within a region of the human genome identified as likely to harbor a susceptibility gene 
for schizophrenia, mood disorders and autism spectrum disorders in individuals who do 
not carry the translocation. Numerous investigations have implicated DISC1 and 
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interacting partners in neurodevelopment, adult neurogenesis in the hippocampus and 
synaptic neurotransmission in adulthood (165). In the context of this chapter, it has been 
shown that prenatal immune activation induced by poly (I:C) to mimic viral infection 
produces the behavioral abnormalities previously unseen in mutant DISC1 mice without 
prenatal challenge (94). Therefore, combining genetic mutations and T. gondii infection 
may better model the pathogenesis of cognitive impairments in schizophrenia. 
 
One needs to take into account timing of infection. Prenatal and early postnatal models of 
T. gondii infection mimic different human conditions. Prenatal infection in rodents would 
be related to a situation where circulating anti-parasitic antibodies in the blood of a 
pregnant woman may be potentially pathogenic due to cross-reactivity with the fetal brain 
(166). In contrast, early childhood T. gondii infection seems to be best modeled by pre-
adolescent infection in rodents to affect postnatal development of cortical areas involved 
in cognitive functions (165). A quite different pathophysiological mechanism (e.g., 
altered neurotransmission) could be modeled by infection of adult animals.  
 
Last but not the least, new insights into the mechanisms of cognitive impairments in 
schizophrenia will be obtained with pharmacological studies similar to the one pioneered 
by Webster and her associates who treated the behavioral abnormalities in infected rats 
with antipsychotics and mood-stabilizer medications (8). Further work is clearly needed 
in this direction with existing and new anti-parasitic drugs, cognitive enhancers and 





Available data suggest that T. gondii infection may contribute to cognitive deficits in 
people with schizophrenia. Such abnormalities may be subserved by different 
mechanisms, including alterations in GLU synaptic neurotransmission. However, there is 
a need to generate more sophisticated animal models of infection-induced cognitive 
dysfunction, likely through a combination of genetic and environmental factors, taking 
into account timing of infection and use of pharmacological approaches to further our 
understanding of the pathophysiology of cognitive abnormalities in schizophrenia. All 
such work will hopefully facilitate the development of novel therapeutics to aid those 
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     CHAPTER 4: 
 Toxoplasma gondii strain-dependent effects on mouse behaviour 
   (published in Folia Parasitologica, 2010) 
 
Abstract 
Toxoplasma gondii (T. gondii) reportedly manipulates rodent behavior to increase 
transmission to its definitive feline host. We compared the effects of mouse infection by 
two Type II strains of T. gondii, Prugniaud (PRU) and ME49, on attraction to cat odor, 
locomotor  activity, anxiety, sensorimotor gating, and spatial working and recognition 
memory 2 months post-infection (mpi). Attraction to cat odor was reassessed 7 mpi. At 2 
mpi, mice infected with either strain exhibited significantly more attraction to cat odor 
than uninfected animals did, but only PRU-infected mice exhibited this behavior 7 mpi. 
PRU-infected mice had significantly greater body weights and hyperactivity while 
ME49-infected mice exhibited impaired spatial working memory. No differences in 
parasite antibody titers were seen between PRU- and ME49-infected mice. The present 











Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan parasite found 
worldwide. It infects nucleated cells of all mammals, including humans. However, it 
requires a cat host for sexual reproduction. Therefore it has been suggested that T. gondii 
manipulates rodent behavior to increase transmission efficiency (128).   
 
Rodents have an innate fear of cat odors (167). Infection with Type II T. gondii, 
Prugniaud (PRU) and ME49, has been shown to decrease avoidance of cat odor and 
increase attraction to it without significantly affecting general anxiety and fear, 
suggesting specificity in the type of manipulation by the parasite (138, 168, 169). Many 
studies on the behavioral effect of T. gondii infection have focused on the early latent 
phase (e.g., 4-10 weeks post-infection), after bradyzoite establishment in the central 
nervous system (137, 138, 170-172). Work on behavioral manipulation later in the latent 
phase of the parasite (e.g. >5 months post-infection) is limited (173). Although the 
behavioral effects of PRU and ME49 have been studied before, a direct comparison of 
these strains has not been reported.  
 
The aim of this study was to directly compare the effects of latent infection of two strains 
of Type II T. gondii, PRU and ME49, on mouse behavior. We hypothesized that 
manipulation effects for direct cat transmission (e.g. cat odor attraction) would be similar 
between strains, while behaviors not directly associated with transmission to cats could 
be differentially affected. To this end, attraction to cat odor, open field activity, anxiety, 
pre-pulse inhibition (PPI) of the acoustic startle, and spatial working and recognition 
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memory were tested in mice 2 months post-infection (mpi). In addition, to evaluate 
duration of manipulation for direct transmission, we reassessed attraction to cat odor 7 
mpi.   
 
4.2 Materials and Methods 
 
4.2.1 Animals 
Female BALB/c mice (The Jackson Laboratory, Bar Harbor, ME) were used in this 
study. Animal protocols were reviewed and approved by the Animal Care and Use 
Committee of Johns Hopkins University (JHU). Mice were housed 5 per cage in the JHU 
animal facility with 14.5/ 9.5 hours of light/dark cycle and free access to food and water.   
 
4.2.2 Toxoplasma gondii Culture and Infection  
Prugniaud (PRU) and ME49 tachyzoites were maintained by passage in human foreskin 
fibroblast monolayers. Tachyzoites were released from fibroblasts by using, in 
succession, 18-, 23-, and 27-gauge needles. Parasites were separated from cell debris by 
filter sterilization (Polycarbonate Membrane Filter, Whatman) and resuspended in 
Dulbecco’s phosphate buffered saline (DPBS). Mice (9 weeks old) were either mock-
infected with sterile DPBS or infected with 400 tachyzoites (2 parasites/ μL) 
intraperitoneally. All behavioral studies were performed on the same cohort 2 mpi, and 





4.2.3 Infection Determination  
Infection was confirmed via serology as previously described (174). Briefly, sera were 
collected from mice 9 mpi and IgG antibodies to T. gondii measured by microplate 
enzyme immunoassay. 
   
4.2.4 Aversion to Domestic Cat Urine  
 Mice were habituated to an open-field box (48cm X 45cm X 21cm) for 5 min daily for 
three consecutive days prior to testing. On testing day, 50-mL vial caps containing either 
1-mL of undiluted domestic cat (Johns Hopkins University School of Medicine Deaf cat 
colony) or domestic dog (a pet) urine were placed in diagonal corners. Mice were placed 
in the centre and allowed to freely explore for 10 min while being videotaped.  The 
position of the odors was altered between each mouse to avoid positional bias. Time 
spent near each odor was recorded using Stopwatch+ (Centre for Behavioral 
Neuroscience) by individuals blind to the type of odor. Occupancy was calculated as the 
percent time spent near each odor for the first 5 min of the 10-min trial to evaluate early 
responses to cat odor. Other behavioral tests were run as previously described (72) and 
explained briefly below. 
 
4.2.5 Novelty-Induced Activity  
Novelty-induced activity in the open field was assessed over a 30-min period using 
activity chambers with infrared beams (San Diego Instruments Inc., San Diego, CA, 
USA). Horizontal and vertical activities, stereotypic activities, and time spent in the 
center or along the walls (thigmotaxis) of the chamber were automatically recorded.  
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4.2.6 Spontaneous Alteration and Spatial Recognition Memory 
Y-maze consisting of three arms of equal length, interconnected at 120°, was used as 
described (175) . The test included two sessions, which evaluate spatial working and 
recognition memory, respectively. In the first session we scored the number of 
alternations done by the mouse when all three arms are visited, without entering the same 
arm twice in a row. After 5-7 days, the second session was performed and consisted of 
two trials. During trial 1, one maze arm was blocked and the mouse allowed to freely 
explore the other two arms for 5 min. Trial 2 began after a 30-min delay. During trial 2, 
the mouse was allowed to freely explore all three arms for another 5 min, taking 
advantage of the innate tendency of mice to explore novel unexplored areas (e.g., the 
previously blocked arm). Mice with intact recognition memory prefer to explore novel 
over familiar arms, whereas mice with impaired spatial memory enter all arms equally. 
Motor activity was recorded as number of arms visited for the whole duration of the test. 
Time spent in the blocked arm during the first 2 min of the 5-min test period was used to 
assess spatial memory in mice as the first 2 min of testing have been shown to be most 
sensitive to manipulations (175). 
 
4.2.7 Anxiety  
The elevated plus maze is a cross of two arms that are open to the environment and two 
arms that are enclosed by side and end walls. The arms are connected by a central area. 
The maze is elevated from the floor (75 cm). Mice were placed in the central area of the 
maze facing a closed arm. Explorative behavior was recorded via a video camera. The 
number of open- and closed-arm entries and the time spent in both types of arms were 
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scored. An entry was defined as all four paws in one arm. Anxiety was scored as the 
percentage of time spent in the open arm in relation to the total 5-min test. 
  
4.2.8 Sensorimotor Gating  
Pre-pulse inhibition of the acoustic startle (PPI) was used to assess sensorimotor gating. 
Mice were acclimatized in startle chambers (San Diego Instruments, Inc., San Diego, 
CA) to a 70-dB background noise (continuous throughout the session) for 5 min, 
followed by the presentation of ten 40 ms 120 dB white noise stimuli at 20 s inter-
stimulus intervals (habituation). After habituation, mice were left in the enclosure for 5 
min without presentations of any startle stimuli. Immediately after, the pre-pulse 
inhibition (PPI) session was begun, consisting of six presentations of each trial type in a 
pseudorandom order. The types of trials include: pulse-alone (120-dB, 100-msec, 
broadband burst), omission of stimuli, and four pre-pulse–pulse combinations consisting 
of a 20-msec pre-pulse broadband burst at either: 74, 78, 82, 86 or 90 dB, presented 80-
msec before the pulse. Startle reactivity and PPI were evaluated by separately comparing 
absolute values of the startle amplitudes for different types of trials between three groups. 
Compared to using percentage values of PPI, the absolute values approach provides a 
better evaluation of startle reactivity both at pulse-alone and pre-pulse trials (176). 
 
4.2.9 Statistical Analysis  
Data were tested for normality and if failed were subjected to rank transformation. 
Afterwards, data were analysed using ANOVA with strain of the parasite and time (when 
applicable) as independent variables. In addition, planned Student t-test was used to 
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evaluate cat attraction between the two strains of parasite, and p<0.05 was considered 
significant.  
 
4.3 Results  
We found that both strains of parasite caused comparable cat odor attraction in infected 
mice 2 mpi, but had a differential effect 7 mpi (Fig 4.1). At 2 mpi, compared to control 
mice, infected mice spent significantly more time near the cat odor. In addition, infected 
mice spent more time near the cat odor than dog odor (Fig 4.1A). At 7 mpi, PRU-infected 
mice continued to spend more time near cat odor than dog odor, as compared to controls 
(Fig 4.1B). In contrast, ME49-infected mice now spent comparable time near dog and cat 
odors, similar to control mice. 
Fig 4.1     PRU- and ME49-infection increases 
mouse attraction to cat odor during the first 5 min 
of the 10-min trial 
 
A) Infection increased occupancy near the cat odor 2 
mpi. Control, n=10; PRU-infected, n=6, * denotes p = 
0.032 relative to control; ME49-infected, n=8, # 
denotes p = 0.05 relative to control.  
 
B) Increased occupancy near cat odor 7 mpi. Control, 
n=10; PRU-infected, n=6, * denotes p= 0.066 relative 
to control; ME49-infected, n=8. Error bars denote SEM.  
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Although the effects of the two parasite strains were similar on cat attraction behavior 2 
mpi, behaviors not directly associated with manipulation were differentially affected by 
the two strains of the parasite (Fig 4.2). PRU-infected mice had significantly heavier 
body weights than controls and ME49-infected mice [a group effect, F (2, 25) = 4.77, p = 
0.018], which was abated at 7 mpi [a group effect, F (2, 25) = 1.32, p = 0.287] (Table 1). 
PRU-infected mice also showed increased locomotor activity in the open field, as 
evidenced by the greater number of broken beams compared to control (Fig 4.2A).  In 
contrast, only ME49-infected mice exhibited decreased spontaneous alterations in the Y-
maze, indicative of impaired spatial working memory (Fig 4.2B).  
 
Fig 4.2     Differential effects of PRU- and ME49-infection on mouse behavior  
 
A) Increased locomotor 
activity in open field of 
PRU- but not ME49-infected 
mice. Control, n=10; PRU-
infected, n=6; ME49-
infected, n=8.  
 
B) Impaired spatial working memory in ME49- but not PRU-infected mice. Control, 
n=10; PRU-infected, n=6; ME49-infected, n=8, * denotes p = 0.056 relative to control 
(Student's t-test).  Error bars denote SEM.  
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No effect of either parasite strain was found on spatial recognition memory, anxiety, or 
sensorimotor gating (Fig 4.3). There was no difference in spatial recognition memory 
between groups as evidenced by similar exploration time of the blocked arm during the 
first 2 minutes of testing [a group effect, F (2, 25) = 1.0, p = 0.380] (Fig 4.3A). No 
differences in anxiety were noted between control and either infected group [a group 
effect, F (2, 25) = 0.68, p = 0.517] (Fig 4.3B). Finally, control and mice infected with 
either parasite strain had similar levels of the acoustic startle of the PPI (Fig 4.3C).  
 
Fig 4.3  No effect of 
infection on spatial 
recognition memory, 
anxiety, or sensorimotor 
gating 
 
A) No difference in 
spatial recognition 
memory between PRU- 
and ME49-infected mice 
and controls. Control, 





B) No changes in anxiety between infected and controls. Control, n=10; PRU-
infected, n=7; ME49-infected, n=9.  
 
C) No difference in pre-pulse inhibition of acoustic startle between infected and 
controls. Control, n=10; PRU-infected, n=7; ME49-infected, n=9.  
X-axis: p4, p8, p12, p16, and p20 are intensities of different pre-pulse trials above the 
background noise level (70 dB). Error bars denote SEM. 
 
 
The serology results confirmed infection with PRU and ME49 [a group effect, F (2, 15) = 
1883, p <0.001] and found no differences in serum antibody titres between the two 
groups of infected mice [t-test, p = 0.847] (Table 4.1). 
 
Table 4.1  Average body weight and Toxoplasma gondii antibody titres of infected 
and control mice 
 
PRU-infected mice weighted significantly more than control and ME49-infected mice 2 
mpi. Control, n=10, PRU-infected, n=7; ME49-infected, n=9, * denotes p=0.009 relative 
to control and p- 0.015 relative to ME49-infected mice. No differences in weights were 
seen 7 mpi. 
Control PRU ME49
 2 mpi 25.8 ± 1.34 * 30.6 ± 1.35 25.1 ± 1.15
 7 mpi 27.3 ± 1.08 29.1 ± 1.77 26.3 ± 0.74
 Antibody Titre (O.D.)  9 mpi 0.15 ± 0.06 * 3.77 ± 0.04 3.76 ± 0.03




High antibody titres were present in infected mice as compared to control. Control, n=3; 
PRU-infected, n=6; ME49-infected, n=7, * denotes p<0.001. All data are mean values ± 
SEM.  
 
4.4 Discussion  
The data support our hypothesis that both strains of the parasite comparably manipulate 
behavior associated with direct cat transmission and differentially manipulate behaviors 
not directly associated with feline transmission. However, while mice infected with either 
parasite demonstrated comparable attraction to cat odor at 2 mpi, only PRU-infected mice 
exhibited this behavior 7 mpi.  
 
Our present results appear consistent with previous studies that have reported T. gondii 
infection in wild and laboratory rodents cause attraction to cat predator odor (138, 168, 
169). Somewhat unexpectedly, our findings seem to suggest that duration of 
manipulation, or at least some behavioral manifestations of manipulation, might vary 
between strains of the parasite. Future work is clearly needed to further our understanding 
of possible permanent and transient aspects of the manipulation effects of T. gondii. 
Strain differences in behavioral manipulation may be due to differences in prolonged cyst 
burden. For instance, although at 1 mpi high PRU cyst density was found in many brain 
regions (138) only few ME49 cysts were observed in more chronic infections (144). 
Future studies will directly compare cyst number and localization of PRU and ME49 in 
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different brain regions and at different time points to determine whether this is in fact a 
factor in the transient manipulation of ME49.  
 
Our data is also in line with studies that have shown infected mice display hyperactivity 
and learning and memory impairment (133). For example, studies on mice and rats with 
adult and congenital infection found hyperactivity in infected mice compared to controls 
between 2 and 7 mpi (177-180), similar to what we found with PRU-infected mice. In 
contrast, a study performed in infected mice and rats found decreased locomotor activity 
2-3 mpi (133). Yet another work did not find any significant difference in activity 
between infected and control mice 3 mpi (171), consistent with our finding with ME49-
infected mice. These discrepancies suggest strain-dependence in behavioral effects of T. 
gondii. Although these behavioral changes may not directly increase transmission of T. 
gondii to cats, both locomotor hyperactivity and impaired spatial working memory could 
potentially increase chances of being captured by a predator.  
 
Similar to putative strain-dependent effects in cat attraction, behavioral effects not related 
to direct manipulation may be due to a number of factors. For instance, it is possible that 
cyst localization differs between strains. It has been shown that the amygdale of PRU 
infected mice contain high cyst density (138). It is conceivable that individual strains may 
have variable tropism to other brain regions, differentially affecting other behaviors than 
just innate fear. Behavioral differences may also be due to infection of different cell 
types. It is also possible that strains elicit varying immunological responses, resulting in 
dissimilar alterations in neurotransmission as the three clonal lineages of T. gondii differ 
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in their modulation of cytokine secretion (10). However, direct comparison of the effects 
of different strains within and between lineages on behavioral manipulation, 
neurobiology, and neuroimmunology need to be done to better understand mechanisms of 
behavioral effects caused by this parasite. Differential susceptibility of behaviors to 
parasite strains might partly explain the broad spectrum of behavioral abnormalities in 
animals and clinical manifestations in humans infected with T. gondii (5, 181).  
 
In conclusion, our data indicate that infection with T. gondii, PRU and ME49, produced 
comparable attraction to cat odor in mice 2 mpi. We also found that the degree of 
attraction and the effects on other mouse behaviors may be influenced in a parasite strain-























     CHAPTER 5: 
 Sex-specific changes in gene expression and behavior induced by chronic  
    Toxoplasma infection in mice 
    (published in Neuroscience, 2012)  
 
Abstract  
There is growing evidence that Toxoplasma gondii modifies the behavior of its 
intermediate hosts.  We investigated the molecular basis of these infection-induced 
behavioral changes, followed by five related behavioral tests to assess the extent of 
biological relevance.  Gene expression signatures were generated in the frontal cortex of 
male and female mice during the latent stage of infection.  We found marked sex-
dependent expression differences in mice.  In female mice, Toxoplasma infection altered 
the expression of genes involved in the development of the forebrain, neurogenesis, 
sensory and motor coordination (i.e., downregulation of fatty acid binding protein 7 and 
eyes absent homolog 1, upregulation of semaphorin 7A).  In male mice, infection led 
mainly to modulation of genes associated with olfactory function (i.e., downregulation of 
a number of olfactory receptors and dopamine receptor D4,  upregulation of slit homolog 
1).  While infection appears to affect the olfactory function in male mice, it is female but 
not male mice exhibited attraction to cat odor.  In contrast, infected male mice showed a 
deficit in social transmission of food preference.  In contrast to males, infected females 
displayed locomotor hyperactivity in open field.  General olfaction and sensorimotor 
gating were normal in both male and female infection.  Our results indicate that the sex of 
the host plays a major role in determining variable brain and behavior changes following 
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Toxoplasma infection.  These observations are consistent with heterogeneity of 






Toxoplasma gondii is a common protozoan which infects humans and other animals.  
Felines serve as the primary host in which Toxoplasma can undergo sexual reproduction 
and complete its life cycle.  Humans, rodents, and other non-feline vertebrates can 
become infected with Toxoplasma and serve as intermediate hosts.  After a short phase of 
acute toxoplasmosis, the infection proceeds into its latent phase, characterized by parasite 
cyst presence in the central nervous system and muscular tissue (182).  The latent phase 
of infection, except in individuals with an immature or suppressed immune system, has 
been considered to be asymptomatic.  Results of animal and human studies of personality 
profiles, behavior, and psychomotor performance have led to a reconsideration of this 
assumption (17, 134, 138, 144, 168, 174, 183, 184).  For example, infected rodents show 
impaired learning and memory as well as increased activity (144).  One of the most 
remarkable changes is that Toxoplasma infection can convert the rodents’ natural 
aversion to feline odors into attraction (134, 138), presumably, in order to alter the 
behavior of the host to benefit the parasites’ sexual cycle (144).  In humans, persistent 
Toxoplasma infection has been associated with increased rates of serious psychiatric 
disorders, suicide, accidents, and reduced psychomotor performance (17, 174, 183, 184).  
Such behavioral changes induced by latent toxoplasmosis have been reported to differ 
depending on the sex of the host: males have shown lower rule-consciousness and greater 
jealousy, while females showed promiscuity and greater conscientiousness (18).  
The molecular mechanisms of altered behaviors in secondary hosts have not been 
elucidated.  We have recently shown that infection of a human neural cell line with 
Toxoplasma tachyzoites (acute infection) results in the altered transcription of a number 
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of different genes associated with a wide range of biological functions (185).  Fouts and 
Boothroyd (2007) have compared the gene expression profile in human foreskin 
fibroblasts (HFFs) infected with tachyzoites or bradyzoites for 48 hours and found no 
dramatic differences in the abundance of host mRNAs (186), although compared to 
tachyzoites, bradyzoites induced a lesser effect on genes involved in cytokine- and 
chemokine-signaling.  
 
In this study, we examined the effects of persistent Toxoplasma infection on gene 
expression in the frontal cortex of male and female mice.  In addition, in a separate 
cohort, we assessed behavioral abnormalities suggested to be changed by microarray 
analysis.  The sex-dependent alterations in gene expression and mouse behaviors suggest 
the sex of the host plays an important role in the response to Toxoplasma infection.   
 
5.2 Experimental Procedures 
 
5.2.1 Animals   
Male and female BALB/c mice (9 weeks old, The Jackson Laboratory, Bar Harbor, ME) 
were used in this study.  Animal protocols were reviewed and approved by the Animal 
Care and Use Committee of Johns Hopkins University (JHU).  All experiments 
conformed to the U.S. National Institutes of Health Guide for the Care and Use of 
Laboratory Animals, and all efforts were made to minimize the number of mice used and 
their suffering.  Mice were housed 1-4 per cage (initially 5 per cage) in the JHU animal 




5.2.2 Toxoplasma culture and infection  
 Prugniaud (PRU) strain was maintained by passage in human foreskin fibroblast (HFF) 
monolayers.  Tachyzoites were released from cells by using, in succession, 18-, 23-, and 
27-gauge needles.  Parasites were separated from cell debris by filter sterilization 
(Polycarbonate Membrane Filter, Whatman) and resuspended in Dulbecco’s phosphate 
buffered saline (DPBS).  Mice of each sex were either mock-infected with sterile DPBS 
or infected with 400 tachyzoites (2 parasites/μl) intraperitoneally.  
 
5.2.3 Sample preparation and microarray analysis   
Surviving mice (infected female: n=5; infected male: n=5; female control: n=5; male 
control: n=4) were sacrificed approximately 6 month post infection and the frontal 
cortices harvested.  At this time, sera were also collected and IgG antibodies to 
Toxoplasma measured by microplate enzyme immunoassay to confirm infection (Xiao et 
al., 2009).  Total RNA was harvested using the RNeasy reagent (QIAGEN, Valencia, 
CA).  The RNA concentration and integrity was determined using Agilent BioAnalyzer 
(Agilent, Santa Clara, CA).  RNA transcript levels were quantified by microarray 
analyses.  Briefly, total RNA was used to generate biotin labeled cRNA using the 
Illumina TotalPrep RNA Amplification Kit (Ambion, Austin, TX).  Biotinylated cRNAs 
were purified, fragmented, and subsequently hybridized to Illumina Mouse Ref-8 v2.0 
Expression BeadChips (Illumina, San Diego, CA).  Each BeadChip has 24,000 well-
annotated RefSeq transcripts with approximately 30-fold redundancy.  The arrays were 
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scanned using an Illumina BeadStation 500X Genetic Analysis Systems scanner and the 
image data extracted using Illumina GenomeStudio software, version 3.0. 
 
Data were analyzed using GeneSpring software v. 11.0.2 (Silicon Genetics, Redwood 
City, CA).  Raw data were imported into GeneSpring and normalized using global 
normalization.  The normalized data were used to identify changes in gene expression in 
the 2 group comparisons: male infected vs male control and female infected vs female 
control.  For statistical analysis, one-way ANOVA was initially performed for each gene 
to identify statistically significant gene expression changes between the two groups, 
followed by Benjamini and Hochberg correction to control the false discovery rate.  
Genes whose transcripts with a FDR-adjusted p-value of < 0.02 and a fold change of > 
1.7 in either direction were considered statistically significant and termed differentially 
expressed genes (DEGs).  This cutoff was set based on previous success of verifying 
expression levels of genes at or above this level by real-time PCR (Cadet et al., 2010).  
 
5.2.4 Data mining   
Gene Ontology analysis was conducted for DEGs using the Spotfire analytic platform 
(http://spotfire.tibco.com).  Selected genes were compared against the universe of 
unselected genes at each level of annotation and for each a p-value was calculated 
according to a hypergeometric distribution that represents the probability that the gene-
functions are randomly distributed between groups (187). Pathway and function analyses 
were generated using Ingenuity Pathway Analysis (IPA, http://www.ingenuity.com, 
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Mountain View, CA) which assists with microarray data interpretation via grouping 
DEGs into known functions and pathways.  
 
All microarray data obtained in this study have been deposited in the National Center for 
Biotechnology Information Gene Expression Omnibus (GEO, 
http://www.ncbi.nlm.nih.gov/geo) public repository, and they are accessible through 
GEO accession (GSE31207). 
 
5.2.5 Real-Time PCR   
To validate DEGs, the same RNA used for microarray was used for real-time quantitative 
PCR.  Real-time analysis was following previously published procedures (Xiao et al., 
2011).  Briefly, the RNA was first treated with TURBO DNA-free DNase (Applied 
Biosystem, Foster City, CA) to remove trace amounts of genomic DNA.  Reverse 
transcription was performed using Multiscribe reverse transcriptase and random primers 
as recommended by the manufacturer (Applied Biosystem, Foster City, CA).  The fold 
changes between groups were evaluated using relative quantization (delta Ct method) 
with β-actin endogenous controls (demonstrating low variation from microarray 
analysis).  The selection of genes was based on the strength of the findings and relevance 
to neurological function.  
 
5.2.6 Behavioral assays   
Behavioral assessments were performed on a separate cohort of mice 2-4 months post 
infection, at the time when chronic infection has developed (139).  Toxoplasma has been 
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shown to impair the normal estrous cycle and makes female mice infertile at as early as 1 
month post infection (188). Thus, by the time of our behavioral testing, female mice were 
unlikely to be cycling.  
 
Behavioral tests were conducted in the following order: aversion to bobcat odor (a 
commonly used model for Toxoplasma-specific manipulation), pre-pulse inhibition of the 
acoustic startle (a predicted behavioral change from gene expression profiles in female 
mice to measure sensorimotor gating), open-field test (a commonly used model to assess 
novelty-induced activity in Toxoplasma infected mice), the buried food test (check 
olfactory ability to make sure there are no olfactory deficits would interfere with 
performance and produce false positive results), and social transmission of food 
preference test (a predicted behavioral change from gene expression profiles in male mice 
to evaluate olfactory based learning and memory).  The strain of mice and infection 
conditions were the same as described earlier.   
 
5.2.6.1  Aversion to bobcat urine   
Aversion to cat urine was tested using a 3-chambered apparatus (40 x 20 x 20 cm each 
chamber) typically used to test social interaction (189).  Mice were allowed to freely 
explore the chamber for 5 min each of 3 days prior to testing.  Testing was performed 
with 50-mL vial caps containing either 1-mL of undiluted mink or bobcat urine 
(Murray’s Lures and Trapping; Walker, WV).  The goal was to test whether Toxoplasma 
manipulates the behavior of its intermediate host to increase transmission to a feline 
predator (bobcat) as compared to a non-feline predator (mink).  Two caps with the same 
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odor were placed in either side chamber, keeping the middle empty.  Mice were placed in 
the middle chamber and allowed to freely explore all chambers for 60 min.  Time spent in 
either side chamber was automatically recorded (LabVIEW 8.5.1, National Instruments).  
Occupancy was calculated as the percent time spent in each odor chamber during the 60-
min trial.  
 
5.2.6.2  Sensorimotor gating  
Prepulse inhibition (PPI) of the acoustic startle was used to assess sensorimotor gating as 
described previously (134).  Briefly, the PPI test is initiated with a 5-minute acclimation 
period to startle chambers (San Diego Instruments, Inc., San Diego, CA), followed by 
different trial types: acoustic startle pulse alone (white noise, 120-decibel (dB)/100-
msec); five pre-pulse trials (P1 to P5) set at 74, 78, 82, 86, or 90 dB precede the pulse by 
80-msec, and finally omission of stimuli was presented to measure the baseline 
movement.  The background noise was a white noise of 70 dB.  Startle reactivity and PPI 
were evaluated by comparing absolute values of the startle amplitudes for different types 
of trials between groups. 
 
5.2.6.3  Novelty-induced activity  
Novelty-induced activity was examined in computerized Digiscan (Omnitech 
Electronics) activity monitors. The experimental chambers consisted of clear Plexiglas 
cages measuring 16×16×12 in. (40×40×30.5 cm) with a row of infrared monitoring 
sensors mounted every 5 cm along the perimeter at the base and a second row of sensors 
mounted at a height of 10 cm. The total number of beams broken was automatically 
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recorded over a 30-min period. For each sex, total beams broken by each infected mouse 
were normalized to the mean of total beams broken by the sex matched control group. 
For example, a normalized value for infected female mouse #1 was calculated as follows: 
(total beams broken by mouse #1/ average of beams broken by all control female mice) * 
100%.  The normalized data for infected mice were used for statistical analysis.  
    
5.2.6.4  Olfactory Acuity  
Olfaction was assessed using the buried food test (190).  Mice were food deprived to 74-
91% of their body weight.  Testing was performed in a clean cage (11 in X 6.5 in X 5 in).  
Briefly, a familiarized food pellet was buried 2 cm below bedding on one side of the 
cage.  Mice were placed in the cage as far from the food as possible.  The time for the 
mouse to locate the food pellet was recorded using a stopwatch. 
 
5.2.6.5  Social transmission of food preference (STFP)  
Olfactory memory was assessed as described by Wrenn et al., (2004) (191), with 
modification to the testing apparatus as described below.  The test consisted of 4 phases 
conducted over 3 days: habituation to food jars (Day 1), feeding demonstrator mice, and 
observing interaction between demonstrator and observer mice (Day 2), and testing food 
preference in observer mice (Day 3). 
 
5.2.6.5.1 Jar and Food Preparation  
Glass canning jars (4 oz, 6.5 cm diameter, 5.5 cm height) with a hole (1-1.4 cm diameter) 
cut in the centre of each lid were used to minimize spillage of food.  Jars were filled 4 cm 
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with fresh bedding and topped with powdered food.  Powdered food was created by 
crushing familiarized food pellets.  Flavoured food was prepared by mixing powdered 
food with either cocoa (2%) or cinnamon (1%).  Weight of the food jars were taken 
before and after each test to calculate the amount of food eaten.  
 
5.2.6.5.2 Habituation to food jars  
Mice were food deprived for 18 hours.  One mouse from each home cage was chosen at 
random to be the demonstrator mouse.  The demonstrator was single housed immediately 
prior to habituation.  Two food jars containing unflavored powdered food were placed at 
opposite ends of the demonstrator mouse cage.  Mice were allowed to freely eat for 1 
hour.  Food jars were then placed in the home cage for 1 hour and mice were allowed to 
freely eat.  Pellet food was returned to all cages at the end of habituation.  Demonstrator 
mice remained single housed and kept in an area of the housing room separate from the 
home cage.  
 
5.2.6.5.3 Feeding demonstrator mice  
Demonstrator mice were food deprived for 18 hours.  Two jars containing the same 
flavoured powdered food was added to opposite ends of the cage and mice allowed to 
freely eat for > 1 hour.  The flavoured food each demonstrator received was randomized.  






5.2.6.5.4 Observing interaction between demonstrator and observer mice  
After demonstrators were fed with flavoured food, they were returned to the home cage.  
Muzzle-muzzle interaction between the demonstrator and each observer mouse was 
recorded for 30 minutes.  
 
5.2.6.5.5 Food preference of observer mice  
Observers were food deprived for 18 hours and single housed immediately prior to 
testing.  One food jar of each flavour was placed in each testing cage.  The placement of 
each flavoured food jar was randomized.  Mice were allowed to freely eat for 1 hour and 
the eating amount of cued versus amount of noncued food were recorded. 
 
5.2.7 Statistical analysis 
Data were analyzed independently for males and females using mixed-design ANOVA 
by SigmaStat version 3.10 (Systat Software, Inc., Chicato, IL, USA).  Significant effects 
were explored further with lower levels ANOVAs and/or post hoc comparisons.  P < 0.05 




5.3.1 Differential effects of Toxoplasma on gene transcription of male and female 
 mice 
 
5.3.1.1  Gene expression profiling in frontal cortex in the initial cohort  
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A summary of the effects of Toxoplasma infection on gene expression of frontal cortex is 
depicted in Table 5.1.  In infected female mice, a total of 124 gene transcripts were 
modulated by latent toxoplasmosis representing approximately 0.52% of the total gene 
set analyzed by the array.  Among them, 64 (51.6%) were upregulated and 60 (48.4%) 
were downregulated.  Similarly, a total of 153 gene transcripts representing 
approximately 0.64% of the total gene set were modulated in infected male mice, 80 
(52.3%) being upregulated and 73 (47.7%) downregulated.    
 
Table 5.1  Number of differentially expressed RefSeq genes and altered canonical  
       pathways 
                    
* denotes FDR-adjusted p < 0.02; > 1.7 fold change in expression 
** denotes p < 0.05 
 
There were only 5 gene transcripts that overlapped between infected female and male 
mice groups (Prg2, Slpi, Sema7a, Amotl2, Vapb).  Three of these genes (Prg2, Slpi, 
Vapb) were modulated in the same direction, while two of them (Sema7a, Amotl2) in the 
opposite direction.  There were two gene transcripts (Tsc22d3, Enox2) modulated in 
chromosome X in female mice, Tsc22d3 upregulated and Enox2 downregulated.  In 
contrast, Zfp185 was the only gene transcript that upregulated in chromosome X in male 
Sex No. of altered pathways **
Upregulated Downregulated
Male 80 73 7
Female 64 60 14
No. of Ref Seq genes *
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mice.  There were no Y chromosome genes which were modulated in male mice.  
 
5.3.1.2  Canonical pathways among DEGs during Toxoplasma infection   
We performed IPA on each dataset of DEGs to identify altered canonical pathways.  In 
infected female mice, the most significant pathways (p < 0.01) were all signaling 
pathways.  These included three immune response pathways (OX40 signaling pathway, 
allograft rejection signaling, and cytotoxic T lymphocyte-mediated apoptosis of target 
cells) and one disease-specific pathway (neuroprotective role of THOP1 in Alzheimer's 
disease).  These signaling pathways appeared to be inhibited, since the majority of DEGs 
within these pathways were down-regulated.  In infected male mice, lipid metabolic 
pathway “androgen and estrogen metabolism” was highly affected (p < 0.01). 
 
5.3.1.3  Identification of brain-related biological processes  
 In both sexes, Toxoplasma infection resulted in remarkable changes in the expression of 
genes associated with the nervous system. 
 
5.3.1.3.1 Nervous system development  
 In Toxoplasma infected female mice, a total of 15 GO categories, including 9 DEGs 
corresponded to nervous system development were enriched (Fig. 5.1A; Eya1, Fabp7, 
Chl1, Sox2, Sema7a, Smarcd1, Nodal, Tnfrsf12a, and Tacc3).  A large proportion of these 
9 genes (4 out of 9 or 44.4%; Fabp7, Sox2, Nodal, and Tacc3) corresponded to genes 
implicated in the brain development.  More specifically, it was remarkable that 75% of 
the genes (3 out of 4; Fabp7, Sox2, and Tacc3) were implicated in forebrain 
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development.  Further analyses revealed that dysregulation was implicated in 
diencephalon development, interkinetic nuclear migration, adenohypophysis 
development, and cell proliferation in forebrain.  Also noteworthy, a good proportion of 
these 9 genes (3 out of 9 or 33.3%) corresponded to genes implicated in neurogenesis 
(Fabp7, Sox2, and Tacc3) as well as regulation of neuron differentiation (Eya1, Sox2, and 
Tnfrsf12a).  
 
In Toxoplasma infected male mice, a total of 8 GO categories, including 9 genes 
corresponding to nervous system development were enriched (Fig. 5.1B; Foxn4, Dpysl2, 
Arsb, Sema7a, Bmp6, Ablim1, Slit1, Aqp1, and Glis2).  Most altered processes involved 
the single gene of Slit1, e.g. telencephalon cell migration, axon extension involved in 
axon guidance, tangential migration from the subventricular zone to the olfactory bulb, 
and regulation of axon extension involved in axon guidance.  Similarly, ventricular 
system development and lateral ventricular development involved another common 





Fig 5.1    Enriched biological processes and their relationships involved in nervous 
system development by Toxoplasma infection.  
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A) Female mice, B) Male mice. Shown are the biological processes with significant p-
value changes in mice altered by persistent infection. Altered genes in each process are 
listed. Upregulated genes appear in bold, and downregulated genes are in italic.   
 
5.3.1.3.2 Neurological system process  
 In Toxoplasma infected female mice, a total of 8 GO categories, including 12 genes 
exhibit signs of enrichment in neurological system process (Fig. 5.2A; Fabp7, Chl1, Myc, 
Sox2, Ppef2, Rdh8, Pdyn, Olfr10, Olfr1404, Olfr142, Olfr156, and Olfr622), with the 
majority being upregulated.  Interestingly, there were 5 olfactory receptors, all of which 
were upregulated.   However, the neuromuscular process, including equilibrioception and 
pre-pulse inhibition appears to be inhibited, since all the DEGs (Fabp7, Sox2) within this 
process were down-regulated.  Similarly, the sensory perception of sound could be 
inhibited also because genes within this process (Myc, Sox2) were downregulated.     
 
In Toxoplasma infected male mice, a total of 6 GO categories, including 14 genes exhibit 
signs of enrichment in neurological system process, with the majority being down-
regulated (Fig.5. 2B; Drd4, Olfr670, Olfr373, Olfr213, Olfr485, Olfr207, Olfr1496, 
Olfr493, Olfr47, Tas2r140, Kcnv2, Aqp1, Olfr1436, and Olfr564).  It is interesting to note 
that 92% of these genes (13 out of 14) corresponded to genes implicated in cognition as 
well as sensory perception.  More specifically, 76.9% genes (10 out of 13) were 
implicated in sensory perception of smell.  Among them, 8 were downregulated (Olfr670, 




Fig 5.2   Enriched 
biological processes and 
their relationships 
involved in neurological 
system process by 
Toxoplasma infection 
 
A) Female mice, B) male 
mice. 
Shown are the biological 
processes with significant 
p-value changes in mice 
altered by persistent 
infection. Altered genes 
in each process are listed. 
Upregulated genes appear 
in bold, and 
downregulated genes are 
in italic.  
 
5.3.1.4  Real time PCR validation  
 In Toxoplasma infected female samples, we analyzed one up-regulated gene (Sema7a) 
and three down-regulated genes (Enox2, Eya1, Pabp7, Prg2),  and in infected male 
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samples, four up-regulated genes (Bmp6, Lmf2, Slit1, Olfr1436) and three down-regulated 
genes (Jph2, Prg2, Drd4).  In general, the fold-changes obtained by qPCR were lower 
than those obtained in the microarray analyses.  No signal was detected in qPCR for 
Olfr1436 by 45 cycles.  Out of the 11 genes tested, 10 showed a positive correlation with 









Fig 5.3   Correlation between microarray and real-time PCR data  
The scatter plot compares mean expression of infected cells/ controls ratios for nine 
genes. Each point represents the infected cells/ controls ratio from the microarray (X-
axis) and real-time PCR (Y-axis). The Pearson correlation coefficient is indicated on the 
scatter plot. For interpretation of the references to color in this figure legend, the reader is 
referred to the Web version of the published version of this chapter (140). 
 
5.3.1.5  Comparison analysis between infected female and male mice   
To identify differences in neurological functioning between infected females and males, 
the genes that were differentially regulated were compared using IPA.  The analysis 
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revealed that behavior function was affected more in infected females than males by 
comparing the extent to which the significances change (7.67E-3 vs 4.49E-2).  Infected 
females had changes in genes involved in 5 specific behaviors: place aversion, ultradian 
rhythm, feeding, acoustic startle response, and mechanical allodynia, while infected 
males had changes in genes involved in only 1 specific behavior: olfactory memory.  Of 
this list of behaviors, olfactory memory and pre-pulse inhibition were tested further, due 
to the association of these behaviors with schizophrenia. 
 
5.3.2    Differential effects of Toxoplasma on the behavior of male and female  
  mice 
 
5.3.2.1     Effect of Toxoplasma infection on body weight and antibody titers of  
  male and female mice  
 Both male and female mice infected with T. gondii showed a significant decrease in 
body weight (Table 5.2).  This decrease was observed 4 weeks post infection, prior to the 
start of all behavioral tests, and remained throughout the course of experiments.  High 
anti-Toxoplasma antibody titres were found in sera of infected male (3.82 ± 0.06) and 
female (3.85 ± 0.05) mice.  There were no differences in serum antibody titers between 






Table 5.2  Average body weight (g) of infected and control mice throughout the 
course of behavioral test 
 
All data are mean values ± SEM (g). 
mpi denotes month post infection 
 
5.3.2.2      Differential effects of Toxoplasma on the behavior of male and female  
  mice   
We found that infection produced differential effects on avoidance of feline odor, 
olfactory memory, and locomotor activity in male and female mice.  We first tested 
whether the T. gondii specific manipulation of decreasing rodent aversion to cat odor is 
seen in both sexes.  Two-way ANOVA for the data for female mice found a significant 
effect of odor, F (1, 35) = 4.496, P = 0.042.  Planned t-test detected that infected female 
mice spent significantly more time near bobcat odor as compared with time spent near 
mink odor (t = 3.11, Df = 32, P < 0.05).  In contrast, no differences in time spent near 
either odor between infected and uninfected male mice were observed, all F < 1; Ps > 
0.05 (Fig. 5.4).  
Control Infected Control Infected
Preinfection 26.8 ± 0.5 26.6 ± 0.5 21.3 ± 0.5 20.8 ± 0.5
1 mpi 28.3 ± 0.6 24.7 ± 0.6 23.5 ± 0.7 18.7 ± 0.7
2 mpi 29.2 ± 0.6 27.1 ± 0.5 24.8 ± 0.8 19.5 ± 0.9
3 mpi 31.2 ± 0.6 29.0 ± 0.5 26.9 ± 1.1 20.1 ± 1.1




Fig 5.4   Effect of infection on aversion to cat odors during a 60-min trial. Ordinates 
depict the occupancy in the target quadrant 
 
A) Infection abolished aversion to bobcat urine in female mice. * denotes p< 0.05 relative 
to mink odor. Female control mice, n=10; infected female mice, n=8 
 
B)  Infection did not affect aversion to cat odors in male mice. Male control mice, n=10; 
infected male mice, n=15. Error bars denote SEM. 
 
 
We tested olfactory memory through the social transmission of food preference (STFP) 
task.  No effect of food novelty was seen in the female group, F (1, 25) = 1.245, P = 
0.277.  In contrast, two-way ANOVA detected a significant effect of food novelty for 
male mice, F (1, 31) = 9.502, P = 0.005.  Planned t-test showed that control males 
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consumed significantly less novel food than familiar food (t = 4.29, Df = 28, P < 0.05).  
No difference in novel and familiar food consumed was found in infected male mice, P > 
0.05 (Fig 5.5). 
 
 
Fig 5.5  Effect of infection on social transmission of food preference (STFP). 
Ordinate depicts preference for the food 
 
A)  No infection effects were found in STFP in the female group. Female control mice, 
n=8; infected female mice, n=5. 
 
B)  infection caused a deficit in STFP in the male group. Male control but not infected 
male mice had signficiant preference for the cued food; * denotes p< 0.05. Male control 




To determine whether differences seen in STFP were because of differences in the 
number of interactions during the observation phase or impairment in smelling ability, we 
assessed social interactions and tested olfactory acuity via the buried food task.  We 
found no difference in the number of observer mouse sniffs between control and infected 
females (F (1, 12) = 0.429, P = 0.526) or males (F (1, 15) = 1.042, P = 0.325).  In 
addition, we observed no significant effects of infection on olfaction in males and 
females as evidenced by no differences between the groups in time spent finding the 
buried food pellet, F (1, 39) = 0.418, P = 0.522.  
 
We measured the effect of Toxoplasma infection on novelty induced activity in male and 
female mice using open field test.  As depicted in figure 5.6, infection had the opposite 
effects on male and female mice.  When the distance traveled by infected mice was 
normalized to the one in the sex-matched control group, one-way ANOVA detected that 
infected female mice were hyperactive while infected male mice displayed hypoactivity, 
F (1, 21) = 8.07, P = 0.01.    
 
Fig 5.6  Female infection increased locomotor 
activity in the open-field arena compared with 
male 
 
The ordinate depicts the normalized values of 
beams broken by the infected mice. For each sex 
group, total beams broken by each infected mouse were normalized to the mean of total 
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beams broken by the corresponding control group. Female control mice, n=10; infection 
female mice, n=8; male control mice, n=10; infected male mice, n=14. * denotes p = 
0.015 relative to male mice. Error bars denote SEM. 
 
 
No effects of infection were found on the magnitude of the acoustic startle or pre-pulse  
inhibition in either sex (Fig. 5.7).  Two-way repeated measures ANOVA for the data did 
not reveal any effect of infection, all Ps > 0.05. 
 
Fig 5.7  Infection did not 
influence prepulse inhibition in 
A) females and B) males 
 
X-axis: p4, p8, p12, p15, and p20 
are intensities of different prepulse 
trials above the background noise 
level (70 dB). Error bars denote 
SEM. Female control mice, n=10; 
infected female mice, n=8; male 
control mice, n=10;  infected male 






A convincing body of evidence exists to support that Toxoplasma can cause specific 
behavioral changes in its host.  In this study, we sought to identify the molecular changes 
that result from persistent Toxoplasma infection in mice.  Using a whole genome 
microarray, we observed that male and female mice exhibited unique frontal cortex 
transcriptome responses to infection.  The sex-dependent changes in gene expression 
were supported by or agreed with sex-specific effects of Toxoplasma infection on several 
behavioral abnormalities.  Consistency between differences in gene expression and 
behavior strengthens the significance of sex-dependent effects of Toxoplasma, although 
additional studies are required to more directly elucidate gene expression-behavior 
relations.  The study suggests that specific sex-parasite interactions influence the 
behavior of intermediate hosts in important ways and that these behavioral changes 
increase the likelihood of predation. 
 
5.4.1 Neurological effects in male mice  
In male mice, the most striking alteration in expression was found for the genes involved 
in cognitive perception of smell with a very selective tropism to olfactory receptors (Fig. 
5.2B).  The majority of altered olfactory receptors appeared to be down-regulated (8 out 
of 10), although there were 5 different olfactory receptors up-regulated in female mice.  It 
is possible that some odor molecules that act as ligands for repressed receptors have been 
eliminated, while other molecules that specialize in binding to the increased receptors 
have been added.  Slit1 (slit homolog 1), significantly upregulated, was involved in 
several altered processes of the central nervous system in male mice.  Slit1 expressed in 
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the septum appears to repel olfactory bulb axons as they project into the lateral olfactory 
tract (192).  Consequently, the increased expression of Slit1 could inhibit the processing 
of olfactory information.  These changes are specific and suggest the existence of subtle 
dysregulation of brain function because olfactory acuity is still intact.  This is consistent 
with a recent report that Toxoplasma manipulates the rodent’s behavior mainly through a 
specific compromise in olfaction without affecting other behaviors (138).  Although the 
olfactory changes could increase the risk of specific predation since this behavior is a 
primary mean of gathering information for a nocturnal species with poor visual acuity, it 
should be noted that the infected male mice did not show preference for bobcat urine 
odor.  An explanation for this outcome is that these altered olfactory genes might not be 
responsible for cat odor detection.  This hypothesis seems to be consistent with our 
finding that the same genes were not affected in infected female mice that did exhibit cat 
odor attraction, possibly as a result of the parasite manipulation of the olfaction 
mechanisms.  In fact, given the deficient performance of infected male mice in the test 
for social transmission of food preference, it is tempting to speculate that the olfaction 
genes affected in male mice might be involved in cognitive processing of olfactory 
stimuli.  
 
Another possible reason for deficient memory observed in infected male mice in the test 
could include the altered expression of DAD4 (dopamine receptor D4).   Laviolette et al. 
(2005) demonstrated that blockade of DAD4 directly in the medial prefrontal cortex 
(mPFC) blocked the acquisition of olfactory fear conditioning in awake, behaving 
animals as well as the encoding and expression of emotional learning in individual 
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neurons of the mPFC (193).  They inferred that signaling through mPFC DAD4 
substrates may be involved in the regulation of neuronal plasticity mechanisms and 
memory processes necessary for adaptive emotional learning and sensory processing.  It 
is possible that the downregulated DRD4 observed in male mice (Fig. 5.2B) contributes 
to the deficits in the STFP (Fig. 5.5).  Indeed, the dopaminergic system has been 
implicated in social learning (194).  Moreover, the deficit is in agreement with previous 
reports which found that rodents infected by Toxoplasma become less neophobic and 
more willing to approach a novel object or odor (144).  In contrast to male mice, food 
preference was not observed in the female mice in the current study.  This observation is 
inconsistent with some previous reports (194, 195).  However, Ryan et al.’s reported 
(2010) a similar pattern with no preference for the cued food in female C58/J and 
C57BL/6J mice as measured by the amount of food consumed (196).  This may be due to 
the difference in the mouse strains used for the experiments.  Further studies are needed 
to elucidate the difference for this test.   
 
Abnormalities in dopamine signaling have been linked to schizophrenia (197).  The 
atypical antipsychotic clozapine, which is effective in treating refractory schizophrenics, 
displays a 10-fold higher affinity for the D4 receptor than the D2 and D3 receptors (198, 
199). These facts suggest that the D4 receptor is a potential target for mediating 
clozapine’s antipsychotic effects.  Previously, we have shown a possible association 
between Toxoplasma infection and an increased risk of human neuropsychiatric disorders 
(174).  In addition, there is evidence that polymorphisms present in the DAD4 gene play 
a role in the etiology of autism (200).  Recent studies suggest Toxoplasma infection may 
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trigger development of autistic spectrum disorders (201).  It is of note that increased 
levels of dopamine have been observed in the brains of mice chronically infected with 
Toxoplasma (20, 150). 
 
5.4.2 Neurological effects in female mice  
In female mice, Toxoplasma infection appears to modify multiple neurological processes 
related to maturation of the forebrain, neurogenesis, sensory and motor coordination (Fig. 
5.1A, 5.2A).  Several studies have investigated the innate fear of laboratory rodents 
toward cat odors (202-204).  These studies have delineated a neuroanatomical circuit in 
the medial hypothalamic zone (MHZ), with input from several forebrain sites as critically 
involved in the organization of innate defensive behavior.  Interestingly, the specific 
alteration in expression of genes involved in maturation of the forebrain (diencephalon 
and adenohypophysis included) that correlated with decreased aversion to cat odor (Fig. 
5.4) was observed in infected female mice.  Moreover, the specific modulation of the 
development of forebrain was observed previously on neural cells infected by 
Toxoplasma (185).  These alterations appeared specific to only those behavioral traits 
likely to enhance predation toward definitive host is in agreement with previous reports 
(169) and supports the manipulation hypothesis.  
 
An effect of Toxoplasma infection on neuromuscular processes, including 
equilibrioception and the acoustic startle was indicated by gene expression in female 
mice (Fig. 5.2A).  No changes in the acoustic startle responses were found although prior 
studies have reported motor deficits (such as motor function, balance, grip strength and 
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coordination) in infected mice (139, 173).   The reasons for our inability to demonstrate 
differences in the acoustic startle are not clear. There is a possibility that the test used 
were not sensitive enough to detect neuromuscular deficits should these deficits actually 
exist in infected mice.  In addition, the effect of latent toxoplasmosis on locomotor 
activity showed an opposite direction in infected male and female mice (Fig. 5.6).  The 
finding is consistent with previous results which reported that decreased activity in 
infected male (173), but increased activity in female (134).   
 
The data presented here provide evidence that Toxoplasma can produce sex-dependent 
changes in mice.  Our results are consistent with previous findings on sex differences in 
human behaviors induced by latent toxoplasmosis (15, 18) and in susceptibility to 
Toxoplasma infection in mice (145).  Potential explanations for this phenomenon might 
include: a) differences in the localization of bradyzoites to the brains of male and female 
rodents, with differential functional consequences; b) sex difference in the length of cyst 
burden; c) differential sex-related neuroimmunological responses to Toxoplasma 
infections (205); and d) the general increased susceptibility of female mice over male 
mice to Toxoplasama infection could be playing a role in the observed differences. 
     
5.5 Conclusion 
Overall, this chapter demonstrates sex-dependent effects of Toxoplasma on gene 
expression and behaviors in its intermediate host.  Our results support the notion that 
Toxoplasma has a high degree of selection for host manipulation.  The postulated 
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mechanisms that might contribute to the development of various neurological and 
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     CHAPTER 6: 
 The Effect of Mouse Age during First Exposure to Toxoplasma gondii on  
   Behavior and Brain Alterations  
 
Abstract  
Toxoplasma gondii (T. gondii) infection has been shown to manipulate rodent behavior. 
Studies have centered around the effect of first exposure during adulthood or congenitally 
on behavioral manipulation. Infection during adolescence, a period during which the 
brain is still developing and maturing, has not been studied. Here we look at the effect of 
T. gondii exposure during adolescence and adulthood, specifically targeting changes to 
pre-pulse inhibition of the acoustic startle behavior in mice. In addition, we describe 
changes in monoamines and serum antibodies to the NR2 subunit of the N-methyl-D-
aspartate receptor (NMDAR). This study shows that the age at which mice are infected 












6.1  Introduction 
Rodents infected with the protozoan parasite Toxoplasma gondii (T. gondii) have been 
shown to exhibit altered behaviors. Studies have focused on the effect of chronic T. 
gondii infection, with first exposure either congenitally or during adulthood (e.g. 6-8 
weeks old) (134, 138, 141, 142, 151, 178, 206). Surprisingly, no work has been done on 
the effect of first exposure to T. gondii during adolescence (e.g. 4-5 weeks old).  
 
The effect of prenatal exposure to pathogens on brain development and behavior has been 
a large focus of research (207). However, the effect of exposure to stressors during 
adolescence on adult behavior has been gaining attention (88, 208, 209). It is now better 
understood that the brain is vastly changing during adolescence, and disruption during 
this critical period could have significant consequences later in life. Important brain 
changes during adolescence include maturation of interneuron, projections of 
mesocortical dopamine neurons, and decreased glutamatergic synapse density (19). 
Therefore, T. gondii infection during adolescence may result in greater or different 
behavioral abnormalities than previously observed with adult infection due to disruption 
of on-going brain maturation. In order to test this hypothesis, we directly compared the 








6.2  Material and Methods 
 
6.2.1  Animals 
Male BALB/c mice (The Jackson Laboratory, Bar Harbor, ME) were used in this study. 
Animal protocols were reviewed and approved by the Animal Care and Use Committee 
of Johns Hopkins University (JHU). Mice were housed 5 per cage with 14.5/ 9.5 hours of 
light/dark cycle with free access to food and water. 
  
6.2.2  Toxoplasma tachyzoite purification 
Prugniaud (PRU) tachyzoites were maintained in human foreskin fibroblast monolayers 
(HFF) and purified as previously described (CITE). Mice were either intraperitoneally 
mock-infected with sterile Dulbecco’s phosphate buffered saline (DPBS) or infected with 
400 tachyzoites (2 parasites/ µL) at 4.5 or 9 weeks of age.  
 
6.2.3  Behavioral Testing 
Behavioral testing was performed 2-4 months post-infection (mpi), with the following 
tests and order used: open field, pre-pulse inhibition of the acoustic startle (PPI) with 
saline administration; PPI with MK801 (0.1 and 0.3 mg/kg) administration; PPI with 
saline administration; PPI with amphetamine (5 mg/kg and 10 mg/kg) administration. 






6.2.3.1   Novelty-induced activity of the open field 
Novelty-induced activity was assessed in the open field (San Diego Instruments). 
Individual mice were placed in the center of the arena and allowed to freely move. 
Central, peripheral, and rearing beam breaks were automatically recorded in 5 minute 
intervals over the 30 minute trial. The periphery was designated as 2.5 cm on all sides. 
Total activity was calculated by summing peripheral and central beam breaks.  
 
6.2.3.2   Pre-pulse Inhibition of the Acoustic Startle 
Sensorimotor gating was assessed using pre-pulse inhibition of the acoustic startle (PPI). 
Mice were intraperitoneally injected with 200 µL bacteriostatic 0.9% sodium chloride 
(Saline) (Hospira, INC; Lake Forest, IL), 0.1 mg/kg or 0.3 mg/kg (+)-MK801 hydrogen 
maleate (Sigma-Aldrich), and D-amphetamine hemisulfate salt C-II (Sigma-Aldrich) 5 
min prior to placement in PPI chambers (San Diego Instruments).  All drugs were diluted 
with saline and prepared fresh in the morning of use for each individual mouse. In the 
testing apparatus (San Diego Instruments), mice were acclimatized to a 76dB background 
noise for 5 min. They were then given 10 presentations of a 120dB pulse and 10 
presentations of no pulse. This was followed by 5 presentations in randomized order of a 
120 dB pulse, no pulse, or pre-pulses with a pulse (77, 78, 80, 84, 88 dB- 120 dB). The 
intervals between each presentation varied from 10-19 seconds. Mean PPI % was 
calculated by averaging all PPI% values for presentations of all pre-pulses for each 
experimental group. The mean PPI% for each infection group was normalized to that of 




6.2.4  Brain Processing for H&E Staining 
Brains were fixed using standard procedures. Briefly, mice were anesthetized and blood 
cleared with 1X phosphate-buffered saline (PBS). Brains were perfused with 4% 
paraformaldehyde (PFA) and once removed from skull, immersed in 4% PFA overnight 
at 4°C. The following day PFA was removed and brains immersed in 10% sucrose 
dissolved in PBS (3X) overnight at 4°C. On the next day, the sucrose solution was 
replaced with 30% sucrose solution in 3X PBS and stored at 4°C until the brains sank. At 
this point, brains were quickly frozen in -50°C methyl-butane and stored at -80°C until 
sectioning. 
 
Hemispheres were separated using a razor blade. One hemisphere was sectioned using a 
sliding microtome (Fisher Scientific, HM450). Each section (40 µM) was immediately 
placed in anti-freeze buffer (pH 6.5) and stored at -20°C until staining. 
 
Sections were stained with hematoxylin and eosin (H&E) following standard procedures. 
Parasite cysts were visualized and counted under brightfield illumination in a blinded 
manner. 
 
6.2.5  Infectivity Confirmation 
Blood was taken at the culmination of behavioral testing and centrifuged at 10,000xg to 
collect serum. Total anti-Toxoplasma IgG was measured via enzyme-linked 




6.2.6  NR2 Antibody Measurements 
Serum antibodies to NR2 were measured using Gold Dot NR2 Antibody Test Kit (CIS 
Biotech, Inc; GD1-001). The kit protocol was followed with one modification. Rather 
than incubation with Protein A-HRP, samples were incubated with anti-mouse IgG 
(1:40000) and the reaction later developed with ABTS peroxidase substrate. 
 
6.2.7  Monoamine Analysis 
Monoamine measurements were made using high-performance liquid chromatography 
(HPLC) analysis. Brain regions obtained from each animal were weighed, ultrasonicated 
in 0.01 M perchloric acid, and centrifuged at 20,000 xg for 15 min. Concentrations of 
norepinephrine (NE), dopamine (DA), 3, 4-dihydroxyphenylacetic acid (DOPAC), 
homovanillic acid (HVA), serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) 
were measured in brain tissue extracts by HPLC with electrochemical detection as 
described earlier (210, 211). In brief, the analytical column was Sunfire C-18 (5 μm, 
4.6×150.0 mm; Waters); the mobile phase was 0.01 M sodium dihydrogenphosphate, 
0.01 M citric acid, 2 mM sodium EDTA, 1 mM sodium octylsulfate, 10% methanol, pH 
3.5 at flow rate 1.0 ml/min and temperature 25°C. The installation consisted of 717 Plus 
automated injection system, 1525 binary pump, a thermostat (all from Waters, USA) and 
a Coulochem III electrochemical detector (ESA). The electrode was set at +0.75 V. Peak 
areas and monoamine concentrations were calculated with Breeze 3.3 software (Waters). 





6.2.8  Statistical Analysis 
Data were first checked for normality and equal variance using SPSS (v.21). If failed, 
non-parametric Mann-Whitney U test was performed to compare age-matched DPBS and 
infection groups. A p ≤ 0.05was considered significant. 
 
6.3  Results 
We first determined whether the age at which a mouse is initially exposed to T. gondii 
affects susceptibility to the psychostimulants MK-801 or amphetamine in pre-pulse 
inhibition (PPI) of the acoustic startle. As indicated by data normalized to mock-infected 
control mice, we found different alterations in PPI upon psychostimulant administration, 
dependent on the age mice were first infected with T. gondii (Fig 6.1). Mice infected with 
T. gondii as juveniles showed decreased PPI with 0.3 mg/kg MK-801 compared with 
saline and 0.1 mg/kg. In contrast, mice infected as adults displayed increased PPI with 
0.3 mg/kg MK-801 as compared with saline and 0.1 mg/kg MK-801 (Fig 6.1A). 
Differential effects due to the age of infection were also observed with amphetamine 
administration (Fig 6.1B). We found that while juvenile infected mice did not show 
significant disruption in PPI with amphetamine, mice infected as adults had increased PPI 
with amphetamine administration (10 mg/kg). Regardless of age of infection, both doses 
of MK-801 increased startle while both doses of amphetamine decreased startle in all 
groups (data not shown). Taken together, our data indicate that the age at which mice are 
administered T. gondii can differentially impact susceptibility to psychostimulants, 




Fig 6.1 Age of host when 
infected with T. gondii affects 
pre-pulse inhibition (PPI) 
susceptibility to MK-801 and 
Amphetamine 
 
A) PPI alterations with 0.1 and 0.3 
mg/kg MK-801. 
 
B) PPI alterations with 5 and 10 
mg/kg amphetamine. 
Juvenile saline and amphetamine, 
n=15; Adult saline and 
amphetamine, n=18 
 
* denotes p< 0.05 compared to 
saline; ‡ denots p< 0.05 compared 
to 0.1mg/kg; ^ denotes p= 0.055 
compared to saline 
 
To rule out the possibility that differences in behavior between the juvenile and adult 
groups are due to differences in infectivity, we measured mouse body weights, serum 
antibodies to T. gondii, and parasite cysts in the brain (Table 6.1). We found that prior to 
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infection (0 days post infection; dpi) and at the end of behavioral testing (117 dpi), mouse 
body weights did not differ between the infected and control groups for either age of 
infection. Yet, at the start of behavior testing (70 dpi) both juvenile and adult infected 
groups weighed significantly less than controls (p< 0.05). Infection at either age elevated 
serum anti-Toxoplasma antibodies by 117 dpi, but these levels did not differ between 
juveniles and adults. Furthermore, there was no significant difference in the number of 
parasite cysts found in the brains of juvenile and adult infected mice.   
 
Table 6.1 Mouse weights, anti-IgG levels in serum, and Cyst numbers 
 
* denotes p< 0.05 as compared with age matched control. Data represents mean ± SEM. 
Body weights and serology: Juvenile DPBS, n=10; Juvenile PRU, n=15; Adult DPBS, 
n=10; Adult PRU, n=18 
 
Cyst counts: Juvenile and Adult DPBS, n=3; Juvenile and Adult PRU, n=4-5. 5 sections 




As differences in PPI susceptibility to amphetamine may be related to monoamine 
changes, we measured the levels of neurotransmitters and their metabolites in the 
striatum and hippocampus of mice chronically infected with T.gondii (Table 6.2). We 
found no monoamine changes in the hippocampus of mice infected as adults, as 
compared with DPBS infection controls. In contrast, the homovanillic acid (HVA) to 
dopamine (DA) ratio and 5-Hydroxyindoleacetic acid (5H1AA) to serotonin (5HT) ratio 
were significantly increased in the hippocampus of mice infected as juveniles, while DA, 
norepinephrine (NE), and 5HT were significantly decreased by infection. In the striatum, 
regardless of age infected, T. gondii lead to a decrease in DA and an increase in 
HVA/DA. This suggests that juvenile infection increases serotonin metabolism in the 
hippocampus and dopamine metabolism in the hippocampus and striatum. In contrast, 
adult infection may decrease DA production in the striatum. Thus, our findings indicate 
that the age of the host when first exposed to T. gondii can differentially alter 


































Table 6.2 Monoamine Changes due to T. gondii infection. 
Table 6.2 Monoamine changes in the striatum and hippocampus of juvenile and adult infected mice 
 
* denotes p< 0.05 compared with control 
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PPI susceptibility to the N-methyl-D-aspartate receptor (NMDAR) antagonist MK-801 
indicates potential dysregulation of the glutamate system. To explore this possibility, we 
measured serum antibodies to the NMDAR subunit NR2. Intriguingly we found that 
infection with T. gondii as a juvenile lead to elevated serum antibodies to NR2 as 
compared with infection controls (Fig 6.3). Infection during adulthood did not elevate 
NR2 antibodies as compared with controls, but both groups had elevated antibodies 
compared to juvenile infection controls. Surprisingly the same three groups with elevated 
anti-NR2 antibodies had susceptibility to MK-801 (0.3 mg/kg) in PPI (Fig 6.1).  
 
Fig 6.2  Anti-NR2 antibody in serum 
Juvenile DPBS, n=10; PRU, n=18; 
Adult DPBS, n=9; PRU, n=18. * 
denotes p< 0.05 
 
 
6.4  Discussion  
Here we have shown for the first time that exposure to T. gondii during adolescence can 
lead to different behaviors and changes in the brain than those seen following parasite 
exposure during adulthood. Consistent with previous findings, we have shown that T. 
gondii infection did not alter pre-pulse inhibition (PPI) of the acoustic startle behavior in 
adult infected mice (134, 140). Unexpectedly, infection during pre-adolescence (juvenile) 
also did not alter PPI. This suggests that infection during perinatal brain development was 
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not sufficient to alter neuronal connections to a degree that would strongly affect rodent 
behavior.  
 
Administration of psychostimulants has been shown to stimulate behavioral alterations in 
rodents.   Here we report for the first time that administration of the psychostimulants 
MK-801 and amphetamine can lead to different alterations in PPI in juvenile and adult 
infected mice, implicating the age mice are infected on the modulation of different 
neurotransmitter systems.  
 
We found that MK-801 administration led to a PPI deficit in juvenile infected mice, but 
PPI facilitation in adult infected mice. Indeed, PPI inhibition and facilitation are both 
observed in patients with schizophrenia, suggesting that rodent infection with T. gondii as 
juveniles or adults can model these two populations of patients with schizophrenia (212). 
Our behavioral results with MK-801 suggest juvenile and adult infection impairs the 
glutamate system differently. MK-801 is a specific NMDAR antagonist that can induce 
PPI disruption in rodents in a dopamine independent manner (213, 214). This PPI 
disruption is suggested to be due to the action of MK-801 on multiple brain regions and is 
not specific to action on the hippocampus alone (214). It is therefore plausible that 
differences in PPI susceptibility to MK-801 may be due to alterations in NMDAR subunit 
composition in multiple brain regions (e.g. decreased subunits in juvenile infected mice 




To explore the possible contribution of NMDARs to MK-801 behavioral changes, we 
looked at the level of serum antibodies to the NR2 subunit of the NMDAR. Antibodies to 
the NMDAR have been associated with encephalitis and psychiatric disorders in patients 
(215). Further, the mechanistic action of MK-801 has been shown to depend on the NR2 
subunit (216). Consistent with a previous report, we found T. gondii infection increases 
levels of serum antibodies to NR2 in mice (217). However, while we found elevated 
antibody levels as compared with controls in the juvenile infected group, antibodies were 
elevated in the control and infected adult groups. The anti-NR2 antibody levels in the 
juvenile group are consistent with the PPI deficits observed in that group. It is plausible 
that juvenile infection with T. gondii increases antibodies to NR2 that lead to a decrease 
in NMDARs, and consequently affect behavior.  
 
We also found differences in PPI in juvenile and adult infected mice after amphetamine 
administration. While adult infected mice exhibited a deficit in PPI after amphetamine 
administration, there was no impairment in juvenile infected mice. Amphetamine has 
been shown to induce PPI deficits in different mouse strains by stimulating the release of 
pre-synaptic dopamine (218). Our behavior results therefore suggest differences in 
dopamine content due to the age of infection.  
 
Indeed, we found a number of changes in monoamines due to T. gondii infection in the 
striatum and hippocampus of juvenile and adult-infected mice. Most striking is that 
juvenile infected mice show a decrease in striatal and hippocampal dopamine, while adult 
infected mice show a decrease in only striatal dopamine. This difference may partly 
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explain the behavioral change seen in adult infected mice after amphetamine 
administration.  However, a decrease in dopamine due to T. gondii infection is contrary to 
previous findings (150, 151, 219). Differences in the mouse and parasite strain used in 
the studies, as well as the age at which mice were infected and how long after infection 
samples were collected may play a large role in discrepancies of neurotransmitter levels.  
 
Taken together, our study shows that juvenile and adult infection with T. gondii can lead 
to different brain and behavioral changes in mice. These changes may be indicative of 
different mechanisms by which T. gondii affects neurodevelopment, and subsequently 
behavior. While T. gondii infection appears to have an overall consequence on the 
glutamate and dopaminergic system, our data suggests that juvenile infection may have a 
greater impact on dysregulation of the glutamate system, while adult infection may have 
a greater impact on dysregulation of the dopamine system. Future work should focus on 







      




     CHAPTER 7: 
 One Minute Ultraviolet Exposure Inhibits Toxoplasma gondii Tachyzoite 
Replication and Cyst Conversion without Diminishing Host Immune Response  
 
Abstract  
We developed a protocol to inactivate Toxoplasma gondii (T. gondii) tachyzoites 
employing 1 minute of ultraviolet (UV) exposure. We show that this treatment 
completely inhibited parasite replication and cyst formation in vitro and in vivo but 
retained their ability to evoke a robust IgG response in mice. We propose that our 
protocol can be used to study the contribution of the immune response to rodent 















7.1   Introduction 
Toxoplasma gondii (T. gondii) infection is known to affect rodent behavior (128, 134, 
138, 169). While some behaviors, such as aversion to cat odor, are changed by all 3 T. 
gondii clonal subtypes (22), other behavioral alterations, such as novelty-induced 
activity, learning and memory, are to some  extent dependent upon the parasite strain 
(134, 220). It is unclear whether brain and behavioral alterations are due to a direct 
consequence of T. gondii cysts residing in the brain, or an indirect effect of the immune 
response generated following T. gondii infection. To discriminate the contributions of 
direct and indirect effects of T. gondii infection, experimental tools are needed to 
generate an immune response to T. gondii proteins in the absence of active infection. 
 
Tools to induce a T. gondii specific immune response without administration of a fully 
functioning live parasite already exist (221). For example, Toxovax®, a vaccine used to 
protect sheep, is made from a live attenuated Type I strain (222). However, since each 
clonal lineage of T. gondii up-regulates cytokines in a strain-specific manner (10), 
Toxovax® may not be suitable to study behavioral alterations specific to other T. gondii 
strains. Other vaccines made from single or combined purified T. gondii proteins (e.g. 
SAG1, SAG1 + GRA4) are able to stimulate an anti-T. gondii adaptive immune response 
(221), but the host immune response to single and/or denatured proteins may be different 
from the one induced by structurally intact tachyzoites. Consequently, we sought to 
develop a method to prevent T. gondii tachyzoite replication in the host without 




Ultraviolet (UV) irradiation has been shown to inactivate T. gondii tachyzoites. Current 
published protocols are based on a rather prolonged exposure to UV irradiation (i.e. up to 
60 minutes) (223, 224), without clear demonstration that the inactivated tachyzoites are 
able to stimulate the host immune system in the absence of parasite replication or cyst 
production in rodent brains (223-227). Here we describe a new rapid and effective 
method for UV inactivation of T. gondii tachyzoites in just 1 minute. An advantage of our 
method is the use of standard equipment (Stratalinker®), thereby increasing the potential 
for reproducibility of the protocol. We demonstrate that 1 minute of UV inactivation is 
sufficient to completely inhibit in vitro parasite replication and cyst formation in the 
mouse brain, while still leading to a robust immune response in mice. 
    
7.2   Materials and Methods  
Serology and in vitro parasite detection by real-time PCR and cyst staining were 
performed using coded samples with the observer being unaware of their origin. 
 
7.2.1   Parasite purification 
Prugniaud (PRU) tachyzoites (≤  passage 3 in vitro) were cultured and purified as 
previously described (134).  
 
7.2.2   UV-Inactivation of Parasites 
Purified parasites (30 µL) resuspended in Dulbecco’s Phosphate Buffered Saline (DPBS) 
(1x) were added to an ultraviolet (UV)-transparent cuvette (Sarstedt AG & Co) and 
sealed with Parafilm®. The cuvette was placed horizontally in a UV Stratlinker 
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(STRATAGENE, UV Stratalinker 2400) and exposed to UV light for 1, 5, or 15 minutes 
at a power of 3,689.04 µJ/ cm
2
/sec for a total energy exposure of 221342.4, 1106712, or 
3320136 µJ/cm
2
, respectively. This was accomplished by setting the timer on the 
Stratalinker® for 60 minutes, which keeps the emitted power constant, and stopping the 
countdown after 1, 5, or 15 minutes. Control 0 minute UV exposed parasites were added 
to a cuvette but not placed in the Stratalinker®. A schematic of the apparatus has been 
provided (Figure 7.1).  
 
Fig 7.1 Inactivation Apparatus 
A) parafilm covered cuvette containing 
30 uL purified parasite. 
 
B) Placement of curvette (arrow) in 
stratalinker. 
 
7.2.3   Trypan blue Exclusion 
Live and UV-inactivated parasites were checked for damage to the cell membrane via the 
trypan blue dye test. Trypan blue solution (0.4% in PBS, Cellgro) was mixed with 
purified tachyzoites (1:1) and immediately visualized under brightfield using a Nikon 
Eclipse E400 microscope. Images were taken with the program EOS Utility 2.8.1.0 





7.2.4  Parasite Replication Assay 
Purified live and UV-inactivated tachyzoites were examined for in vitro replication 
competency using a modification of an established immunofluorescence procedure (228).  
Tachyzoites were added to HFF cells growing in 8-chamber slides (Millipore). At 2 -9 
days post-infection (37°C, 5% CO2), cell monolayers were rinsed with DPBS, fixed, 
permeabilized and then immunolabeled with rabbit (Rb) anti- SAG-1 (AbD Serotec, UK) 
followed by Alexa Fluor 594 goat anti-Rb (red, Life Technologies).   DAPI (Invitrogen) 
for visualizing host cell nuclei was added to the secondary antibody.  Stained cells were 
examined by epifluorescence using a Nikon eclipse E400 microscope with the program 
MetaVue version 6.2r6. Prior to staining, cells were examined by phase contrast using 
Axiovert 100 (Carl Zeiss) and images taken with Axiovision Rel 4.8.  
 
7.2.5  Parasite Red/Green Invasion Assay  
Purified live and UV-inactivated tachyzoites were examined for in vitro invasion 
competency as previously described (228). Briefly, purified parasites were added to HFF 
cells growing in 8-chamber slides (Millipore). At 1 hour post-infection, cells were rinsed, 
fixed and then immunolabeled with Rb anti-SAG-1. Cells were then permeabilized and 
immunolabeled with MAb 9e11 anti-SAG1 (Argene Inc., NY, USA) followed by a 
mixture of Alexa Fluor 594 goat anti-Rb (red, Life Technologies) to detect 
attached/extracellular tachyzoites and Alexa Fluor 488 (green, Invitrogen). DAPI 





7.2.6  Animals   
Male BALB/c mice, 5 weeks old (The Jackson Laboratory, Bar Harbor, ME) were used 
in this study. Animal protocols were approved by the Animal Care and Use Committee of 
Johns Hopkins University (JHU). Mice were housed 3-5 per cage with 14.5/ 9.5 hours of 
light/dark cycle and free access to food and water.  
 
7.2.7  Mouse Inoculations   
Parasites were purified and UV-inactivated as described above. Alum adjuvant (Thermo 
Scientific) was added drop-wise to inactivated parasite (1:1) with mixing after each drop. 
Positive control innocula consisted of live parasites only. Negative control innocula 
consisted of DPBS and alum adjuvant (1:1). All solutions were placed on a rotating 
shaker (Barnstead Lab-Line) at medium-high speed for 40 min. Mice were injected 
intraperitoneally with  200 µL of either 400 UV-inactivated tachyzoites: alum adjuvant 
(n=5; 2 tachy/µl; 1:1), 40,000 UV inactivated tachyzoites with and without alum adjuvant 
(n=5; 200 tachy/ µL; 1:1); 300,000 UV-inactivated tachyzoites with and without alum 
adjuvant (n=5; 1500 tachy/ µL; 1:1), 400 live tachyzoites (n=4; 2 tachy/ µL), or mock-
infected with DPBS: alum adjuvant (n=3; 1:1).  
 
Boosters were administered 12 days post-infection. Mice first administered UV-
inactivated tachyzoites with and without alum adjuvant or mock-infected with DPBS: 
alum adjuvant were given the same preparations as a booster. Mice first given live 




7.2.8  Serology   
Blood was collected via tail bleed and then centrifuged at 10,000 x g for 10 minutes on a 
table top centrifuge to separate cells from serum. Anti-T. gondii IgG was measured in 
sera using ELISA kits from IBL America (Minneapolois, MN, U.S.A.) modified as 
previously described (174). The primary antibody consisted of diluted serum (1:100) and 
secondary antibody was enzyme labeled anti-mouse IgG.  
 
7.2.9  Parasite Detection in Mouse Brain  
Mice were sacrificed 4 weeks after initial infection, whole brains were excised, and then 
washed with cold 1x PBS. Brains were homogenized by serial passage through 18, 20, 
and 23 gauge needles in sequential order, and then centrifuged at 3,300 RPM for 5 
minutes at room temperature. The pellet was resuspended in 1 mL PBS and divided for 1) 
parasite cyst staining, 2) parasite DNA detection by real-time polymerase chain reaction 
(RT-PCR) and 3) parasite viability.   
 
7.2.9.1  Cyst Staining 
Twenty percent of brain homogenate was stained with Fluorescein labeled Dolichos 
Biflorus Agglutinin (DBA) (1:200; Vector Laboratories) to visualize parasite cysts. 
Stained brain homogenates were examined using Nikon eclipse E400.  
 
7.2.9.2  Real-time Polymerase Chain Reaction 
Thirty percent of brain homogenate was used for TaqMan real-time PCR analysis. DNA 
was extracted from 3 samples of brain homogenate per mouse (10% homogenate/ mouse) 
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using a standard kit (MOBio Tissue Kit, Carlsbad, CA, U.S.A.). Real-time PCR was 
performed for the unique T. gondii 5S rRNA gene (229) using the following primers and 
probe: 5’-TGC TGC GTT CTT CAT CGT-3’ forward, 5’-TGC TTT CAG ATT GCT 
TCC TAA A-3’ reverse, 56-FAM/CGC GAG CCA AGA CAT CCA TTG C/36-TAMSp. 
Mouse beta-actin (Mm00607939 s1, Life Technologies) was run as a housekeeping gene/ 
loading control. Each sample was run in triplicate with 100 ng DNA. The PCRs were 
performed on an ABI7900HT real-time PCR system (Applied Biosystems, Foster City, 
CA). Real-time results were analyzed using SDS 2.4 software (version 2.4; Applied 
Biosystems).  
 
7.2.9.3  Viable Parasite Recovery 
Fifty percent of brain homogenate was used to purify brain cysts. To separate parasite 
cysts from brain cell debris, isotonic percoll was added to brain homogenate and 
centrifuged at 2,400 RPM for 15 minutes at room temperature. The pellet was 
resuspended in DPBS (1X) and centrifuged at 3,300 RPM for 10 minutes at room 
temperature. The remaining pellet was resuspended in HFF medium and plated in 
duplicate on HFF cells cultured on 8-chamber microscope slides (Millipore). After 2 
weeks, cells were washed, fixed, permeablized, stained, and images taken as described 
under the replication assay section.  
 
7.2.10  Statistical Analysis 
Data were first tested for normality using IBM SPSS Statistics 21. If passed, one-way 
analysis of variance (ANOVA) with Bonferroni post-hoc was run with infection as the 
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independent variable. If failed, data were subjected to a Kruskal-Wallis one-way analysis 
of variance by ranks with infection as the independent variable. Mann-Whitney U-test 
was then run to compare specific infection groups at individual time points; p< 0.05 was 
considered significant. 
 
7.3   Results 
We first sought to determine whether UV exposure affects the integrity of the tachyzoite 
cell membrane via the trypan blue dye test. We found that, similar to live parasites, 
purified T. gondii tachyzoites exposed to UV for 1 minute were impermeable to vital dye 
trypan blue whereas longer exposures, i.e. 5 and 15 minutes, resulted in immediate 
intracellular accumulation of the dye (Fig 7.2). We then checked whether the replication 
of 1 minute UV-exposed tachyzoites was compromised. While live tachyzoites 
successfully replicated and eventually lysed host HFF cells, 1 minute UV-exposed 
tachyzoites were unable to replicate (Fig 7.3). As replication may have been affected by 
the inability to invade HFF cells, we performed an invasion assay with 1 minute UV-
exposed tachyzoites. We found that 1 minute UV treatment did not affect the ability of 
tachyzoites to invade HFF cells (Fig 7.3, inset). Based on these results, we selected 1 















Fig 7.2 TrypanBlue Exclusion of UV inactivated tachyzoites  
Purified tachyzoites exposed to UV for 0 or 1 min remain clear in the presence of 
TrypanBlue. Tachyzoites exposed to UV for 5 or 15 min are immediately stained blue. 







7.3    UV exposure prevents in vitro tachyzoite replication  
HFF cells were infected with either live tachyzoites or tachyzoites exposed to UV for 1 
min and then examined microscopically after 9 days. As shown by both phase contrast 
and immunofluorescence, live tachyzoites replicated normally, resulting in cell lysis. In 
contrast, UV-exposed tachyzoites, although able to penetrate the host cells (inset), were 
unable to replicate, leaving only sparse single tachyzoties. 
 
Inset: Red/ green Invasion Assay. See Methods section for details. 
Red and green: Immunofluorescent staining of T. gondii tachyzoite surface antigen 1 
(SAG1) 
 
Blue: Nuclear staining with DAPI 
Scale Bars: 50 µM 
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We first optimized the administration condition and dose of inactivated tachyzoites to 
elicit a robust anti-T.gondii IgG response in mice. As expected, injection of 400 live 
tachyzoites produced a significant increase in anti-T. gondii IgG levels compared to 
injection with adjuvant. We then tested several doses of inactivated parasites with or 
without adjuvant to determine the optimal dose to elicit a robust anti-T. gondii IgG 
response. Neither 400 nor 40,000 inactivated tachyzoites with or without adjuvant 
significantly elevated levels of anti-T.gondii IgG compared to adjuvant only (p>0.05). 
However, injections of 300,000 inactivated tachyzoites with or without adjuvant led to a 
significant rise of anti-T.gondii antibodies as compared to adjuvant (p<0.05) (Figure 7.4). 
The greatest anti-T.gondii IgG response was produced by administration of 300,000 
inactivated parasites with adjuvant compared to that following injection of 400 live 
tachyzoites or 300,000 inactivated parasites without adjuvant (all p<0.05). We therefore 
selected the dose of 300,000 inactivated tachyzoites with adjuvant to be given to mice 
(inactivated group) to compare with mice given live parasite (live group) or adjuvant only 








7.4   Anti-Toxoplasma IgG Levels at 20 days post infection (dpi)  
Live and 300,000 inactivated tachyzoites with and without adjuvant significantly elevated 
anti-Toxoplasma IgG levels in mice 20 dpi. There was a significant group effect 
[H=23.715, 6 d.f., p= 0.0001]. Post-hoc comparisons showed that the antibody levels 
were significantly higher in live, 300,000 inactivated, 300,000 inactivated with adjuvant 
groups vs. adjuvant control and 300,000 inactivated with adjuvant vs. live. * denotes p < 
0.05 relative to adjuvant control. # denotes p < 0.05 relative to live parasites. Error bars 
denote SEM. Adjuvant, n=3; live, n=4; 400 inactivated + adjuvant, n=5; 40,000 
inactivated, n=5; 40,000 inactivated + adjuvant, n=5; 300,000 inactivated, n=5; 300,000 
inactivated + adjuvant, n=5. 
 
In order to better characterize the response to different treatment conditions, we looked at 
the kinetics of the anti-Toxoplasma IgG levels and mouse body weight as a clinical 
symptom of sickness. We found that at 20 dpi anti-Toxoplasma IgG levels were 
significantly higher in the inactivated group compared to the live or adjuvant group 
(p<0.05). However, this difference between the inactivated and live group was resolved 
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by 30 dpi (p>0.05) (Fig 7.5). Despite the presence of relatively high anti-Toxoplasma IgG 
levels in mice of the inactivated group, these animals did not significantly lose weight as 
measured at 0, 10, 20 or 30 dpi (all p>0.05). In contrast, mice of the live group had 
significantly lower body weights compared to mice of the adjuvant or inactivated group 
at 10, 20, and 30 dpi (p< 0.05) (Fig 7.6).   
 
 
Fig 7.5   Kinetics of Anti-Toxoplasma IgG Levels 
Live and inactivated tachyzoites elicit increased IgG levels in mice 20 and 30 dpi. There 
was a significant group effect at 20 and 30 dpi [H=9.726 and 7.477, 2 d.f., p= 0.008 and 
0.024, respectively]. Post-hoc comparisons showed antibody levels were significantly 
lower in the adjuvant group vs. live and inactivated groups at 20 and 30 dpi; inactivated 
IgG levels were higher at 20 dpi vs. live. * denotes p < 0.05 relative to live and 
inactivated groups; # denotes p< 0.05 relative to live.  Error bars denote SEM.Adjuvant, 




Fig 7.6  Kinetics of mouse weight 
 Live-infected mice weighed significantly less than adjuvant controls and 300,000 
inactivated parasite with adjuvant group at 10, 20, and 30 dpi. Adjuvant, n=3; live, n=4; 
inactivated, n=5, * denotes p≤ 0.05 as compared to adjuvant and inactivated administered 
mice. Error bars denote SEM. 
 
We then determined whether the IgG response in mice of the inactivated group was 
associated with viable T. gondii presence in the brain 30 dpi. Viable parasites were found 
in the brain homogenates from mice of the live group but were absent in the homogenates 
from mice of the inactivated group (Fig 7.7). We also looked for the existence of T. 
gondii cysts. Parasite cysts were found in the brains of mice of the live group (n=3) but 
not in the brains of mice of the inactivated group (n=5) (Fig 7.7A). To confirm the 
absence of viable parasites in mice of the inactivated group, their brain homogenates 
were added to HFF cultures. No T. gondii tachyzoite growth was observed from the 
brains of mice given inactivated parasites. In contrast, there was a robust growth of the 
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parasite from the brains of mice given live tachyzoites (Fig 7.7B). To further verify that 
inactivated tachyzoites were not present in the mouse brains, we checked for T. gondii 
DNA via real-time PCR. T. gondii specific 5S rRNA genomic DNA was detected in brain 
homogenates of mice given live parasites, but not in animals given inactivated parasites 
or adjuvant only. Regardless of treatment conditions, the host specific housekeeping 
gene/ loading control Beta-actin was observed in all samples and the levels did not differ 
between groups (p> 0.05) (Fig 7.8).  
Fig 7.7  Parasite cyst presence 
and parasite viability from 
mouse brain  
A) Parasite cyst DBA lectin 
(green) seen in brain homogenates 
of live parasite administered mice 
only.  
B) Parasite tachyzoites grew on 
HFF cells from brain homogenate 
of mice administered live parasite 
but not inactivated parasite.  
Red is immunofluorescent staining 
of tachyzoite SAG1;  Blue is DAPI 
staining of nuclei; Scale bars 






Fig 7.8 Real-time PCR of Toxoplasma 5S rRNA gene 
Brain homogenates only from mice given live T. gondii had detectable levels of parasite 
DNA 30 dpi. No parasite DNA was detected in the brains of adjuvant controls or 
inactivated parasite administered mice. Beta-actin loading control was detected in all 
samples. There was no significant group affect in Beta-actin levels [F(2,9)= 0.206, 
p=0.817]. Adjuvant, n=3; live, n=4; inactivated, n=5. 
 
7.4  Discussion 
The present study indicates that our method of inactivating tachyzoites with 1 minute 
UV-exposure results in a complete inhibition of tachyzoite replication in vitro and 
absence of viable parasites in vivo. Nonetheless, intraperitoneal injection of UV-
inactivated parasites triggered a robust IgG immune response in mice. These results 
suggest that our method of inactivating T. gondii tachyzoites with UV could aid in 
investigating the role of T. gondii-specific immune activation on rodent behavior by 




Our data are largely consistent with prior studies that utilized UV inactivation of T. 
gondii tachyzoites (223-227). For example, we also showed that tachyzoites exposed to 
UV were able to exclude Trypan blue, suggesting irradiation did not damage the 
tachyzoite membrane (225). We found that 1 minute UV-exposed tachyzoites did not 
replicate in vitro, as has been seen by others using UV inactivation of tachyzoites (225, 
226). In addition, we report that mice administered inactivated parasites had a robust 
serological IgG response without a decrease in body weight, as has been previously 
published (223, 227).  
 
In contrast to Grimwood and associates who reported that irradiated tachyzoites can 
infect BHK cells at a rate similar to live tachyzoites (225), we found only a few UV 
inactivated tachyzoites capable of binding and invading HFF cells. It is possible that 
similar rates of infection between live and UV inactivated parasites were not observed in 
our studies due to differences in the cell type used. It is also possible that we did not see 
many inactivated parasites at 9 dpi due to parasite degradation in culture. Indeed, it has 
been shown that inactivated parasites are degraded in macrophage cultures within 48 hrs 
of infection (226).  
 
In contrast to prior studies used UV inactivation, we performed a more thorough 
validation of our method. We confirmed that inactivated parasites were not present in the 
mouse brain 30 dpi as tested with parasite cyst staining, culturing, and real-time PCR. 
However, even if we did not detect any live parasites in the brains of mice from the 
inactivated group at 30 dpi, one cannot completely rule out that a few parasites might 
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have entered the brain but were subsequently cleared. Notably, a transient presence of T. 
gondii in the brain has been suggested to contribute to behavioral abnormalities (22).  
There are several caveats to our study. While the anti-Toxoplasma IgG response to the 
inactivated parasites lasted up to 1 month post infection in vivo, the complete time course 
of this response has not been evaluated. Also, whether the peripheral IgG response is 
associated with or followed by immune activation in the brain has not been assessed. 
Importantly, such a phenomenon has been seen in other models. For example, peripheral 
administration of BCG vaccine to rodents leads to immune activation (e.g. up-regulation 
of cytokines) in the brain (230). 
 
There are a number of potential benefits to using the UV inactivation protocol described 
here to study the role of the host immune response to T. gondii infection in behavioral 
abnormalities. First, in contrast to synthetic immunostimulators such as poly I:C and LPS 
(TLR3 and 4 ligands, respectively), our protocol permits determining the immune 
response specific to T. gondii or even a particular T. gondii strain as the protocol employs 
structurally intact parasites. In this way, there would be greater construct validity to 
animal models of behavioral alterations following T. gondii infection (220, 231). Second, 
our method is faster than previously reported ones that take up to 60 minutes of UV 
exposure (223-227). Third, our protocol uses a standard piece of laboratory equipment, 






7.5  Conclusion 
Here we describe a rapid and straightforward method to reliably inactivate T. gondii 
tachyzoites and stimulate an immune response in vivo. The inactivated tachyzoites are 
incapable of replicating in vitro and in vivo, or forming cysts in vivo, but elicit a strong 
serological anti-Toxoplasma IgG response in mice. This methodology can be 
implemented to study the role of immune activation following T. gondii infection in 
rodent behavioral alterations. In particular, since this method is applicable to the 
inactivation of any T. gondii strain, differences in parasite-strain immune activation can 

















     CHAPTER 8: 
 Immune Response to Toxoplasma gondii Infection Affects Mouse Behavior  
 
Abstract  
The protozoan parasite Toxoplasma gondii (T. gondii) has been shown to modulate 
behavior. It has long been thought the parasite does this during chronic infection as 
parasite cysts persist in the brain. Here we show that behavioral modifications of T. 
gondii infected mice may actually be due to the host immune response to infection, rather 
than the parasite cyst. We show that mice administered live T. gondii (able to produce 
cysts) and inactivated T. gondii (unable to produce cysts) behave similarly in their 
response to the NMDAR antagonist MK-801 in pre-pulse inhibition of the acoustic startle 
and cued memory in fear conditioning. In contrast, live and inactivated T. gondii-infected 
mice show opposite behaviors of anxiety in the dark-light box and possible contextual 
memory deficits in fear conditioning, as well as associative memory in passive 
avoidance. These findings provide evidence that the immune response to T. gondii 










8.1  Introduction 
Toxoplasma gondii (T. gondii) is a protozoan parasite found world-wide that can infect 
any warm-blooded mammal, including humans. Epidemiological studies implicate 
infection with this parasite in schizophrenia and bipolar disorder (6, 129), as well as other 
changes in behavior (5, 15, 17). Rodent behaviors have also been shown to be altered by 
T. gondii infection (128, 134, 138, 141, 169, 220). Yet how infection with T. gondii alters 
behavior is not understood.  
 
One premise is that the continued presence of T. gondii cysts in specific brain regions can 
affect behavior. Indeed, T. gondii cysts have been shown to contain tyrosine hydroxylase 
homologs and produce dopamine, a neurotransmitter associated with many behaviors (20, 
149). Parasite cysts localized in two brain regions (amygdala and forebrain) have been 
associated with predator odor avoidance and anxiety in rodents (138, 232). However, 
other rodent studies were unable to find any regional preference of parasite cysts in the 
brain (233), and there are currently no reports on detection of T. gondii cysts in the brain 
of patients with psychiatric disorders . Thus, it is possible that T. gondii cyst regional 
localization may not be the sole factor contributing to behavioral alterations.  
 
The host immune response to an infection may also contribute to behavioral changes. 
Studies have revealed that peri- and post-natal infection with bacterial and viral mimics 
(LPS and PolyIC, respectively) is sufficient for altering rodent behavior (94, 234, 235). 
Similarly, changes in rodent behaviors have been seen upon administration of bacillus 
Calmette-Guerin (BCG), an attenuated Mycobacterium bovis (230). Furthermore, one 
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study thus far has shown that decreased aversion to cat odor in T. gondii infected rodents 
does not require parasite persistence (22). It is therefore plausible that the host immune 
response to T. gondii infection, rather than the persistence of parasite cysts, plays a large 
role in the development of behavioral modifications.   
 
In this study, we explore the contribution of the host immune response to T. gondii 
infection in altering rodent behavior, with an emphasis on behaviors related to human 
psychiatric disease. Due to parasite strain-specific behavioral changes (134) and cytokine 
responses (236), we utilize a parasite inactivation method previously developed (Chapter 
7), enabling the use of the same T. gondii strain for the live and inactivated parasite 
infections. Here we report new evidence that the immune response to T. gondii infection 
may be sufficient to modify behavior.  
 
8.2  Materials and Methods 
 
8.2.1  T. gondii tachyzoite purification and UV-inactivation 
Prugniaud (PRU) tachyzoites (< passage 4 in vitro) were cultured and purified as 
previously described (134). Purified tachyzoites were inactivated for 1 minute using a 
UV Stratalinker (STRATAGENE, UV Stratalinker 2400) under conditions explained 






8.2.2  Mouse Inoculations 
Male BALB/c mice (Jackson Laboratory, Bar Harbor, ME) were housed 5 per cage with 
14.5/ 9.5 hours or light/dark cycle and free access to food and water in the Johns Hopkins 
University (JHU) animal facility. Mice were injected at 5 weeks of age intraperitoneally 
with either 200 µL Dulbecco’s Phosphate Saline (DPBS), live PRU tachyzoites (400 
tachyzoites/ 200 µL), alum adjuvant diluted in DPBS (1:1) (Invitrogen), or inactivated 
PRU tachyzoites mixed with alum adjuvant (1:1) (Invitrogen; 300,000 tachyzoites/ 200 
uL). Prior to injections, inocula were placed on a shaker for 45 minutes as previously 
described (Chapter 7). Booster injections were administered 12 days post infection (dpi), 
with DPBS and live PRU- infected mice now administered DPBS, adjuvant mice now 
administered adjuvant, and inactivated PRU tachyzoites (300,000 tachyzoites/ 200 uL) 
with alum adjuvant given to mice first given inactivated parasites. The Animal Care and 
Use Committee of JHU approved all protocols.  
 
8.2.3  Behavior Analysis 
Mouse behavior was tested between 2 and 4.5 months post infection (mpi) in the 
following order: open field, pre-pulse inhibition of the acoustic startle (PPI) with saline 
administration, PPI with 0.1 mg/kg and 0.3 mg/kg MK-801 administration, dark-light 
box, passive avoidance, and fear conditioning. All testing was conducted between the 
hours of 3 and 8:30 pm. Data was normalized to infection controls for tests that showed 





8.2.3.1  Novelty-induced activity of the open field 
Novelty induced activity was measured in the open field (San Diego Instruments) in 5 
min bins, over a 30 min trial. Central, peripheral, and rearing beam breaks were 
automatically recorded. The periphery was designated as 2.5 cm on all sides of the 
chamber. Central and peripheral beam breaks were combined to give a measure of total 
activity. Beam break activity in the periphery and center were translated into the time 
spent in each location using the PAS Software (San Diego Instruments). 
 
8.2.3.2  Sensorimotor gating of pre-pulse inhibition of the acoustic startle 
Sensorimotor gating was tested using pre-pulse inhibition of the acoustic startle (PPI). 
Briefly, 5 minutes prior to testing, mice were injected intraperitoneally with 200 µL 
bacteriostatic 0.9% sodium chloride (Saline) (Hospira, INC; Lake Forest, IL) or 0.1 
mg/kg or 0.3 mg/kg (+)-MK801 hydrogen maleate (Sigma-Aldrich). In the testing 
apparatus (San Diego Instruments), mice were acclimatized to a 76dB background noise 
for 5 min. They were then given 10 presentations of a 120dB pulse and 10 presentations 
of no pulse. This was followed by 5 presentations in randomized order of a 120 dB pulse, 
no pulse, or pre-pulses with a pulse (77, 78, 80, 84, 88 dB- 120 dB). The intervals 
between each presentation varied from 10-19 seconds. Mean PPI % was calculated by 
averaging all PPI% values for presentations of all pre-pulses for each experimental group.  
 
8.2.3.3  Dark-light Box  
Anxiety was evaluated using the dark-light box (Colbourn). Mice were placed in the 
transparent side and allowed to freely move for 5 min between the dark and light 
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chambers. The latency for i) each crossing, ii) total time spent on each side, and iii) the 
number of crosses were automatically recorded using Graphic State v 3.03.  
 
8.2.3.4  Fear Conditioning 
Context and cued (tone)-dependent learning and memory were evaluated with fear 
conditioning (Colbourn) over a 3-day trial. All chambers were in custom made 
soundproof enclosures. On day 1, mice were placed in chambers for a total of 5 min. At 2 
min, an 85 dB, 2000 Hz tone was played for 30 seconds. During the last 2 seconds of the 
tone presentation, a 1.0 mA shock (Med Associates, Inc.) was delivered. The following 
day, day 2, contextual freezing was tested. Mice were placed in the same chamber in 
which they were previously shocked. On day 3, cued (tone) dependent freezing was 
tested. Mice were placed in an opaque box that was then placed in the fear conditioning 
chamber for 5 min. At 2 min, mice were presented with an 84 dB-tone, 2000 Hz that 
lasted 3 min. On each day, freezing (%) was automatically recorded in 1 min bins 
(Freezescan, CleverSys Inc).  
 
8.2.3.5  Passive Avoidance 
Associative learning and memory was evaluated using a 2-day passive avoidance test 
(San Diego Instruments). On the first day, training phase, mice were placed in a lit 
compartment with the gate to the dark compartment shut. After 30 seconds, the gate 
opened allowing the mouse to cross to the dark compartment. Once the mouse crossed 
over, the gate automatically closed and after a 3 second delay a 0.3 mA shock was 
administered for 3 seconds. Twenty-four hours later, during the testing phase, the mouse 
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was placed once again in the lit compartment with the gate to the dark compartment shut. 
After 5 seconds, the gate opened allowing the mouse to freely move to the dark 
compartment. The trial ended either when the mouse crossed to the dark compartment, or 
once 10 min elapsed. For each phase, the latency in seconds for the mouse to cross from 
the light to dark compartment was automatically recorded.  
 
8.2.4  Statistical Analysis 
Data was first checked for normality and equal variance using SPSS (v.21). If failed, 
either non-parametric Kruskal-Wallis with multiple comparisons or Mann-Whitney U test 
was performed to compare DPBS and live, adjuvant and inactivated, and live and 
inactivated infection groups. A p ≤ 0.05was considered significant.  
 
8.2.5  Infectivity Confirmation  
Blood was taken at the culmination of behavioral testing and centrifuged at 10,000Xg to 
collect serum. Total anti-Toxoplasma IgG was measured via enzyme-linked 
immunosorbent assay (ELISA) as described previously (174).  
 
8.3  Results  
We evaluated the role of live T. gondii infection and the immune response to T. gondii 
infection on the manipulation of mouse behavior. To do so, we infected mice with either 
live T. gondii tachyzoites (“live mice”), which can replicate and produce parasite cysts in 
the brain, or inactivated T. gondii tachyzoites (“inactivated mice”), which are unable to 
replicate or produce parasite cysts. We first looked at novelty-induced activity in the open 
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field as an indicator of general activity level and possible anxiety. Infection with either 
live or inactivated T. gondii did not change total, central, peripheral, or rearing activity as 
indicated by no significant difference in the number of beam breaks or total time spent in 
each zone as compared with controls (data not shown). 
 
While anxiety and overall activity were unchanged in the open field, mice administered 
live and inactivated T. gondii exhibited altered anxiety levels in the dark-light box. Live 
T. gondii infected mice were more anxious than infection controls and inactivated mice, 
while live mice exhibited decreased anxiety (Fig 8.1). Live parasite-infected mice spent 
greater amount of time in the dark chamber during the first crossover as compared with 
controls and inactivated mice. However, over the entire 5 min trial, inactivated mice 
spent less time in the dark as compared with live mice, and both parasite administered 
mice spent more time in the dark compared with controls (Fig 8.1A, B). Also, live mice 
had transitioned a fewer number of times between the dark and light chambers while 
inactivated mice had greater number of transitions (Fig 8.1C). Taken together, the data 
reveals that live T. gondii infection increases anxiety in mice, while the immune response 




Fig 8.1 T. gondii infection increases mouse anxiety in the dark-light box 
 
A) Normalized time it first took mouse to transition from dark to light chamber 
 
B) Normalized time mouse spent in dark over entire trial 
 
C) Normalized total number of transitions 
 
DPBS, n=9; Live, n=9; Adjuvant, n=7; Inactivated, n=16.  




We also checked the effect of T. gondii infection and the immune response to T. gondii 
infection on two learning and memory tasks: passive avoidance and fear conditioning. 
We found no associative learning and memory impairment in the passive avoidance test 
(Fig 8.2) or fear conditioning (Fig 8.3). In the passive avoidance task, there was no 
difference in the amount of time it took for live and inactivated mice to cross to the dark 
chamber on training day as compared with controls (Fig 8.2A). There was also no 
significant difference between groups in the ratio of testing to training latency (Fig 8.2B). 
However, inactivated mice trended towards a greater testing to training ratio as compared 
with live mice (p< 0.1), suggesting with a greater number of mice, we may be able to see 
an associative learning and memory deficit in the passive avoidance task due to live T. 
gondii infection.  
Fig 8.2  Associative Learning and Memory 
Impairment in T. gondii Infected Mice 
  
A) Normalized latency to cross over to dark 
side during training 
 
B) Ratio of testing latency: training latency 
 
DPBS, n=10; Live, n=9; Adjuvant, n=7; 






In the fear conditioning task, there was no difference between all groups on training day 
in the percent of time the mice froze (Fig 8.3A). There was also no difference in 
contextual memory, as the percent of time the mice froze was comparable between all 
groups. While there appears to be delineation between mice given adjuvant or DPBS as 
the vehicle, this was not statistically significant (Fig 8.3B). Similarly, there was no 
significant difference between the infected groups and controls in cued memory, but now 
the live and infected mice are more closely grouped together in less percent freezing, 
while the controls trended to freezing more (Fig 8.3C). Taken together, this data suggests 
there may be a deficit in cued memory in mice administered live or inactivated T. gondii. 
 
 
Fig 8.3 Contextual and Cued Fear Conditioning is not affected by T. gondii Infection 
Solid horizontal line denotes time and duration the tone (84 dB, 2000 Hz) was delivered. 




As cognitive impairments may be due to problems with information processing, we 
looked at the effect of live and inactivated T. gondii administration on pre-pulse 
inhibition (PPI) of the acoustic startle (Fig 8.4 and 8.5). As infection with either live or 
inactivated T. gondii did not elicit deficits in PPI as compared with infection controls (Fig 
8.4), we wished to determine whether infection would lead to differences in susceptibility 
to the N-methyl-D-aspartate receptor (NMDAR) antagonist, MK-801. Increasing doses of 
MK-801 lead to increased startle in DPBS, live, and inactivated mice (p< 0.01), but not 
adjuvant mice, as compared with the drug controls (saline) in each group (Fig 8.4A). 
Surprisingly, increasing doses of MK-801 lead to deficits in PPI for all infection groups: 
DPBS, live, adjuvant, and inactivated, compared to saline drug controls for each infection 
group (Fig 8.4B). In addition, administration of 0.3 mg/kg MK-801 lead to PPI deficits 
for all infection groups as compared with saline and 0.1 mg/kg MK-801 administration 
(Fig 8.4B). Surprisingly, when all infection groups with 0.3 mg/kg MK-801 were 
compared, we found that live and inactivated mice showed facilitated PP as compared 
with either infection controls, but did not differ from one another (Fig 8.4B). Taken 
together, this data suggests that the immune response to T. gondii infection will lead to a 























































































































































































































































































Because body weight differences may influence behavior, we monitored mouse weights 
over the course of the experiment. There was no significant weight difference between all 
groups during initial infection (0 days post-infection; dpi), at the beginning of behavior 
testing (60 dpi), or at the culmination of behavior testing (128 dpi) (Table 8.1). We also 
evaluated serum anti-Toxoplasma IgG at the end of behavior testing to determine whether 
differences in antibody levels, which suggest infectivity, may explain behavioral 
differences. We found there was a significant elevation of serum anti-Toxoplasma IgG 
due to infection with live and inactivated parasites as compared with controls (p< 0.02), 
but no significant difference between the live and inactivated group (Table 8.1). 
Therefore, any behavioral alterations seen in mice given live and inactivated tachyzoites 
are not due to differences in body weight during testing, nor differences in antibody 
levels.  
 
Table 8.1 Mouse weight and anti-Toxoplasma IgG serum levels 





8.4  Discussion  
The present study indicates that T. gondii cysts do not have to persist in the brain for mice 
to exhibit behavioral changes. Apparently, the host immune response to T. gondii 
infection, in the absence of cyst formation, is a major contributor to behavior 
modifications. This thought is consistent with what has been seen in a study focused on 
decreased aversion to cat odor in T. gondii infected mice (22). However, it is still unclear 
whether some behaviors, such as anxiety, are due to the presence of T. gondii cysts in the 
brain or the immune system. This dilemma may be due to the methodology employed in 
our present study. 
 
For instance, it is conceivable that the inactivated T. gondii tachyzoites may lead to the 
stimulation of some, but not all, toll-like receptors that are stimulated by the live 
parasites. Different toll-like receptors (TLRs) are stimulated by specific T. gondii 
proteins (e.g profilin stimulates TLR11while glycosylphosphatidylinositols stimulate 
TLR2 and 4) (237, 238).  In turn, each stimulated TLR triggers the secretion of specific 
cytokines.  It is possible that while some proteins on the live and inactivated tachyzoites 
are both recognized by the host immune system, other proteins are recognized while the 
live parasite replicates and undergoes conversion to parasite cysts. Therefore, the live 
parasites may stimulate more TLRs and subsequently lead to the secretion of different 
cytokines than with the inactivated parasites.  
 
Another possible explanation for the differences in anxiety between live and inactivated 
mice lies in the time in which the cytokines are up-regulated. For instance, the number of 
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tachyzoites administered to mice has been shown to affect what cytokines are up-
regulated in serum by 6 hours post-infection (237). In our model, the numbers of live and 
inactivated tachyzoites first administered vary by 10
3
 parasites. It is possible that this may 
result in an up-regulation of cytokines in the inactivated mice first, followed by cytokine 
up-regulation in the live infected mice days later when the parasite burden is high enough 
to elicit an immune response.  
 
While there are caveats to our study, it is still clear that T. gondii does not have to be 
present in the brain as parasite cysts in order to have an impact on mouse behavior. It 
would be interesting to discern what specific T. gondii proteins are seen by the host, and 
in turn what TLRs are stimulated that lead to behavior modifications. A better 
understanding of how the host immune response to T. gondii infection affects behavior 
may open the way for a new line of therapies to be used in humans affected by T. gondii. 












     CHAPTER 9:  
   Concluding Remarks and Recommendations 
 
Infection with the parasite Toxoplasma gondii (T. gondii) has been implicated in the 
pathogenesis of psychiatric disorders such as schizophrenia. While approximately 30-
50% of the world's human population is infected with the parasite, not everyone infected 
develops schizophrenia and not everyone with schizophrenia has been infected. Human 
studies have been unable to explain how infection with T. gondii leads to mental illness in 
only some individuals. As rodents can be infected with T. gondii in a manner similar to 
humans, and can also be manipulated in a controlled environment, we sought to use mice 
to determine infection conditions that would lead to behavioral alterations, as a model of 
symptoms of psychiatric disorders. Much work has been done on using mice under 
various conditions to model aspects of schizophrenia in humans (Chapter 2). Some 
studies have also looked at the specific role of T. gondii infection on the development of 
cognitive deficits seen in patients with schizophrenia, although much of the work with 
mice has not been reproduced (Chapter 3). Irreproducibility in behavioral tests with T. 
gondii infected mice may be due to a lack of consistency in the parasite strain, mouse 
strain, age of infection, and behavioral testing conditions used between laboratories. 
 
In the previous chapters of this dissertation I have shown that the strain of Toxoplasma 
gondii (T. gondii) (Chapter 4), the sex of the mouse (Chapter 5), the age in which the 
mouse is infected (Chapter 6), and the presence of T. gondii parasite cysts in the brain 
(Chapter 8) alter different mouse behaviors. While these findings provide insight into 
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infection conditions that lead to symptoms of schizophrenia, more work still needs to and 
should be done to refine the model. 
 
As described in previous chapters, many of the behavioral alterations observed in T. 
gondii infected mice are subtle. This is exemplified by the need for psychostimulant 
administration to observe deficits in pre-pulse inhibition of the acoustic startle (Chapters 
6 and 8). Subtle behavioral changes may be difficult to replicate within and between 
laboratories, and may reflect only slight changes in the neurobiology of the brain. Rather, 
a robust phenotype would suggest striking differences in the brain that would be easier to 
identify. In addition, it would provide a stronger basis for testing pre-clinical compounds 
and looking at mechanisms by which T. gondii infection will lead to deficits.  
 
One avenue to pursue in creating a mouse model with a robust phenotype is infecting T. 
gondii into transgenic mice expressing genes associated with psychiatric disorders. Time 
and again studies have come out showing an environmental or genetic factor alone is 
insufficient to produce a behavioral phenotype in mice. However, when combined, the 
two have a synergistic effect and a phenotype can be observed (239). This may be true 
with T. gondii as well and should be tried. 
 
In addition, more effort needs to go towards understanding the molecular underpinnings 
of behavioral effects of T. gondii infected rodents that are currently observed. While there 
are studies on the behavioral manipulation of T. gondii, and there is new work trying to 
understand how T. gondii infection alters the brain (240), there is no study combining the 
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two and clearly showing that specific brain alterations due to T. gondii infection are what 
is leading to behavioral changes. The field seems to be moving in this direction, and there 
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